dapsone has been researched along with rifampin in 542 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 231 (42.62) | 18.7374 |
| 1990's | 109 (20.11) | 18.2507 |
| 2000's | 95 (17.53) | 29.6817 |
| 2010's | 90 (16.61) | 24.3611 |
| 2020's | 17 (3.14) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bera, S; Mondal, D | 1 |
| Edwards, RP | 1 |
| Ambrose, EJ; Antia, NH; Chulawalla, RG; Khanolkar, SR; Koticha, KK | 1 |
| Hentschel, B | 1 |
| Waters, MF | 5 |
| Freerksen, E; Rosenfeld, M | 3 |
| Choudhury, S; Ghosh, S; Hazra, SK; Kundu, S | 2 |
| Gelber, RH; Helmy, HS; Laing, AB; Pearson, JM; Rees, RJ; Waters, MF | 1 |
| Ambrose, EJ; Chulawalla, RG; Khanolkar, SR | 1 |
| Desikan, KV; Girdhar, BK; Ramu, G | 1 |
| Fujuda, T; Hagiwara, S; Ishihara, S | 1 |
| Faber, WR; Leiker, DL | 1 |
| Languillon, J; McDougall, AC; Yawalkar, SJ | 1 |
| Belda, W; Kliemann, TJ; Lombardi, C; Margarido, LC; Marlet, JM; Martinez, EA | 1 |
| Desikan, KV; Girdhar, BK | 4 |
| Bourland, J; Cap, A; Pattyn, SR; Saerens, EJ; Warnsdorff, J | 1 |
| Gelber, RH; McDougall, AC; Pearson, JM; Rees, RJ; Waters, MF | 1 |
| Browne, SG | 3 |
| Freerksen, E | 2 |
| Kittel, H | 1 |
| Balakrishnan, S; Sheshadri, PS | 1 |
| Michelson, JB; Roth, AM; Waring, GO | 1 |
| Bonnici, E; Depasquale, G; Freerksen, E; Kriiger-Thiemer, M; Rosenfeld, M | 1 |
| Havel, A; Rosenfeld, M | 2 |
| Williams, HW | 1 |
| Jacobson, RR; Trautman, JR | 1 |
| Chapman, RS; Forsyth, A | 1 |
| Pereira, V | 1 |
| Trautman, JR | 1 |
| De Las Aguas, JT | 1 |
| Leiker, DL | 4 |
| McRae, DH; Russell, DA; Scott, GC; Shepard, CC; Vincin, DR | 1 |
| Dockx, P; Pattyn, SR; Rollier, MT; Rollier, R; Saerens, EJ | 1 |
| Gatti, JC | 1 |
| Terencio de las Aguas, J | 1 |
| Alvarenga, AE; Innami, S; Leguizamón, OR | 1 |
| Depasquale, G | 2 |
| Hamzah, M; Kosasih, A | 1 |
| Krenzien, HN | 1 |
| Rohde, R | 2 |
| Gelber, RH; Rees, RJ | 1 |
| Barton, RP | 1 |
| Pfaltzgraff, RE; Steenbergen, GJ | 1 |
| Aschhoff, M | 1 |
| Gelber, RH; Gool, HC; Rees, RJ | 1 |
| Allen, BW; Ellard, GA; Gammon, PT; King, RC; McDougall, AC; Rees, RJ; Weddell, AG | 1 |
| Horowitz, HW; Jorde, UP; Wormser, GP | 2 |
| Ala, J; Hall, JJ; Reeve, PA | 1 |
| Cartel, JL; Grosset, JH; Martin, PM; Moulia-Pelat, JP; Nguyen Ngoc, L; Spiegel, A | 1 |
| Jha, PK; Talwar, S; Tiwari, VD | 1 |
| Chakrabarty, AK; Chattopadhya, D; Kashyap, A; Saha, K; Sahu, A | 1 |
| Banerjee, DK; McDermott-Lancaster, RD | 2 |
| Becx-Bleumink, M | 3 |
| Fiallo, P; Gelber, RH; Gillis, TP; Hill, C; Izumi, S; Job, CK; Williams, DL | 1 |
| Gelber, RH; Lalwani, AK; Tami, TA | 1 |
| Bourland, J; Grillone, G; Groenen, G; Kuykens, L; Pattyn, SR; Stes, P | 1 |
| Gibaldi, M | 1 |
| Devgan, SC; Mittal, A | 1 |
| Banerjee, NR; Jagga, CR; Saha, K; Sahu, A; Sehgal, VN | 1 |
| Anokhina, VV; Eskina, IM; Freĭdlin, IS; Iushchenko, AA; Iushin, MIu; Urliapova, NG; Vishnevetskiĭ, FE; Vishnevetskiĭ, RF | 1 |
| Bulmer, K; Ratledge, C; Wheeler, PR | 1 |
| Britton, WJ; Cho, SN; Failbus, SS; Neupane, KD; Roche, PW; Theuvenet, WJ | 1 |
| Dhople, AM; Gardner, GD; Meindl, W; Schoenenberger, H; Strong, LC | 1 |
| Groenen, G; Janssens, L; Kuykens, L; Mputu, LB; Pattyn, SR | 1 |
| Blok, LM; Bloos, LJ; van den Berg, G | 1 |
| Gilbody, JS | 1 |
| Antia, NH; Mistry, Y; Mukherjee, R | 1 |
| D'Souza, D; Das, BC; Thomas, IM | 1 |
| Gelber, RH | 3 |
| George, S; Jacob, M; Mathai, R | 1 |
| Carolina, JC; Constant-Desportes, M; Grosset, JH; Guelpa-Lauras, CC; Léoture, A; Sansarricq, H | 1 |
| Bagga, A; Katoch, K; Katoch, VM; Natarajan, M | 1 |
| Eberhardt, K; Hartmann, W; Hoose, C; Wosniok, W | 1 |
| Balakrishnan, A; Christian, M; Nagarajan, M; Prabhakar, R; Somasundaram, PR; Thomas, A; Tripathy, SP | 1 |
| Baquillon, G; Husser, JA; Jamet, P; Maiga, M; Pattyn, SR | 1 |
| Chopra, NK; Harshan, KV; Misra, RS; Mittal, A; Nath, I; Prasad, HK | 1 |
| Cottenot, F; Flageul, B; Pennec, J; Vignon-Pennamen, MD; Wallach, D | 1 |
| Desikan, KV; Girdhar, A; Girdhar, BK; Lavania, RK | 1 |
| Makokha, S; Nyawalo, J; Obura, M; Okelo, C; Okuku, P; Orege, PA | 1 |
| Ellard, GA | 4 |
| Aoyagi, T; Toyoda, T | 1 |
| Bhattacharya, SN; Mathur, RP; Sehgal, VN; Sharma, VK | 1 |
| Ji, F; Li, W; Luo, J; Tao, M; Wang, C; Yang, Z; Ye, G | 1 |
| Mengistu, G; Warndorff van Diepen, T | 1 |
| Katoch, K; Ramanathan, U; Ramu, G | 1 |
| Jidoi, J; Saito, H; Tomioka, H; Yamada, Y | 1 |
| Gharpuray, MB; Kulkarni, DS; Kulkarni, V | 1 |
| Timmerman, H; van Saane, P | 1 |
| Katoch, K; Katoch, VM; Ramanathan, U; Ramu, G; Sengupta, U; Sharma, VD; Shivannavar, CT | 1 |
| Bourland, J; Ghys, P; Grillone, S; Groenen, G; Pattyn, SR | 1 |
| Deverchin, J; Ghys, P; Groenen, G; Janssens, L; Pattyn, SR | 1 |
| Kar, PK; Sohi, AS | 1 |
| Alvarenga, AE; Haubitz, I; Leguizamon, O; Pritze, S | 1 |
| Millan, JP; Moulia-Pelat, JP | 1 |
| Chatterjee, G; Ganguly, NK; Kaur, S; Sharma, VK; Vaishnavi, C | 1 |
| Pavithran, K | 3 |
| Felten, MK | 1 |
| Agarwal, JS; Chopra, NK; Pandya, PG | 1 |
| Bhate, RD; Bhate, RP; Chattopadhyay, SP; Gupta, CM | 1 |
| Bagga, AK; Bhatia, AS; Katoch, K; Natrajan, M; Ramanathan, U; Ramu, G; Saxena, RK | 1 |
| Bagga, AK; Girdhar, A; Girdhar, BK; Lavania, RK; Malaviya, GN; Mishra, B | 1 |
| Baohang, J; Grosset, JH; Noordeen, SK | 1 |
| Chatterjee, BR | 2 |
| Duan, CX; Huang, WB; Li, HY; Ma, JF; Yu, XL; Zhang, MS; Zhang, SB; Zhu, K | 1 |
| Ekambaram, V; Rao, MK | 1 |
| Felten, MK; van der Merwe, CA | 1 |
| Hale, WA | 1 |
| Bach, MA; Garraud, O; Ribierre, O | 1 |
| Koranne, RV; Srivastava, G | 1 |
| Li, WZ | 1 |
| Baohong, J; Grosset, JH; Ito, T | 1 |
| Bhatia, VN; Dhandayuthapani, S | 1 |
| Jha, PK; Kar, PK; Panayach, JS; Snehi, PS | 1 |
| Dharmshaktu, NS; Mittal, BN; Rao, CK | 1 |
| Kumar, M; Nigam, PK; Singh, G; Singh, PK | 1 |
| Reddy, PK | 1 |
| Christian, M; Ellard, GA; Jesudasan, K; Pannikar, VK | 1 |
| Chattopadhyay, SP; Gupta, CM | 1 |
| Dutta, RK; Singh, G; Tiwari, VD; Tutakne, MA | 1 |
| Bourée, P; Carré, N; Drahmane, S | 1 |
| Ganguly, NK; Kaur, H; Kaur, S; Sharma, VK; Vaishnavi, C | 1 |
| Aggarwal, SK; Arora, PN; Ramachandra, S; Ramakrishnan, KR | 1 |
| Mohinuddin, SK; Reddy, PK | 1 |
| Grugni, A; Kini, MS; Nadkarni, NJ | 1 |
| Kleeberg, HH | 1 |
| Bourland, J; Grillone, S; Groenen, G; Janssens, L; Pattyn, SR | 1 |
| Baohong, J; Colston, MJ; Matsuo, Y | 1 |
| Grosset, JH | 1 |
| Gelber, RH; Levy, L | 1 |
| Pieters, FA; Woonink, F; Zuidema, J | 1 |
| Ye, GY | 1 |
| Balakrishnan, S; Bhatia, VN; George, J | 1 |
| Girdhar, A; Girdhar, BK; Husain, S; Malaviya, GN; Mishra, B | 1 |
| Boerrigter, G; Fine, PE; Ponnighaus, JM | 1 |
| Chanda, M; Chowdhury, A; Dey, SK; Panja, SK | 1 |
| Chaudhury, S; Chaudhury, SK; Das, PK; Dey, SK; Hazra, S | 1 |
| Chaudhury, S; Chaudhury, SN; Das, PK; Hazra, S; Majumder, V; Poddar, S; Podder, GC; Sarkar, S | 1 |
| Floch, HA | 1 |
| Bach, MA; Cottenot, F; Flageul, B; Hoffenbach, A; Wallach, D | 1 |
| Fieldsteel, AH; Gelber, RH; Humphres, RC | 1 |
| Pattyn, SR | 4 |
| Bahmer, FA; Menzel, S | 1 |
| Desikan, KV; Katoch, K; Ramanathan, U; Ramu, G | 1 |
| Boerrigter, G; Ponnighaus, JM | 1 |
| Onsun, N; Pattyn, SR; Saylan, T | 1 |
| Martinez Cruz, D | 1 |
| Alvarenga, AE | 1 |
| Dietrich, M; Wabitsch, R | 1 |
| Chum, HJ | 1 |
| Gandhi, IS; Mehta, J; Sane, SB; Wamburkar, MN | 1 |
| Andrade, VL; Avelleira, JR; da Cunha, LH; Marques, AB | 1 |
| Nyawalo, JO; Obura, M; Orege, PA | 1 |
| Kar, SK | 1 |
| Bagga, AK; Bharadwaj, VP; Girdhar, A; Girdhar, BK; Mathur, A; Venkatesan, K | 1 |
| Coussens, L; Groenen, G; Janssens, L; Kayembe, T; Nollet, E; Pattyn, SR | 1 |
| Chaturvedi, VN; Jain, SK; Raizada, RM; Rathi, SS | 1 |
| Acharya, VM; Almeida, AF; Dedhia, NM; Khanna, UB; Mittal, BV | 1 |
| Becx-Bleumink, M; van Asbeck-Raat, AM | 1 |
| Bharadwaj, VP; Girdhar, BK; Mathur, A; Venkatesan, K | 1 |
| Altchek, DD | 1 |
| Anderson, R | 2 |
| Ffytche, TJ; McDougall, AC | 1 |
| Buchanan, TM; Harnisch, JP; Knight, J; Young, DB | 1 |
| Ji, BH | 1 |
| Ganapati, R; Maniar, JK; Parikh, AC; Parikh, DA | 1 |
| Rook, GA | 1 |
| Adiga, RB; Fairbairn, T; Samual, S; Samuel, NM | 1 |
| Ito, T; Kohsaka, K; Nagata, Y | 1 |
| Gurnani, S; Rajagopalan, R | 1 |
| Cowie, RL; Langton, ME | 1 |
| Redus, MA; Shepard, CC; Van Landingham, M; Walker, LL | 1 |
| Jopling, WH | 2 |
| Hilson, GR; Holmes, IB | 1 |
| Fasal, P; Levy, L; Shepard, CC | 3 |
| De Muynck, A; Janssens, PG; Pattyn, SR; Rollier, MR; Rollier, R; Verdoolaeghe-Van Loo, G | 1 |
| Draper, GJ; Draper, P; Edwards, RP | 1 |
| Godal, T; Myrvang, B; Samuel, DR; Song, YK | 1 |
| McDougall, AC; Rees, RJ | 1 |
| Matsuo, Y | 1 |
| Drutz, DJ; Levy, L; O'Neill, SM | 1 |
| Rees, RJ | 2 |
| Johnston, SM; Ryan, TJ | 1 |
| Verhagen, AR | 1 |
| Drutz, DJ; Epstein, WV; Fasal, P; Gelber, RH | 1 |
| Pearson, JM; Rees, RJ; Waters, MF | 1 |
| Rees, RJ; Weddell, AG | 1 |
| Shepard, CC | 1 |
| Freerksen, E; Hokama, S; Rosenfeld, M | 1 |
| Ghosh, S; Hajra, SK; Languillon, J; McDougall, AC; Opromolla, DV; Tonello, CJ; Yawalkar, SJ | 1 |
| Desikan, KV; Ramu, G; Sengupta, U | 1 |
| Chaudhury, S; Ghosh, S; Hazra, S; Kundu, SK | 1 |
| Ramu, G | 1 |
| Jones, RL; McDougall, AC | 1 |
| Levy, L | 1 |
| Sansarricq, H | 1 |
| Appa Rao, AV; Krishna, DR; Prabhakar, MC; Ramanakar, TV | 1 |
| Moschella, SL | 1 |
| Bourland, J; Davies, EM; Feracci, C; Grillone, S; Janssens, L; Pattyn, SR; Saylan, T | 1 |
| Keeler, RF | 1 |
| Sandberg, P; Shum, TK | 1 |
| Pruzanski, W; Saito, S | 1 |
| Bonhomme, J; Chalopin, JM; Lucht, F; Portier, H; Rifle, G | 1 |
| Eyckmans, L; Gigase, P; Pattyn, SR | 1 |
| Riley, DN | 1 |
| Andersen, JG; Haimanot, RT; McDougall, AC; Mshana, RN | 1 |
| André, PS; Baquillon, G; Ferracci, C; Pattyn, SR | 1 |
| Ganapati, R; Naik, SS; Revankar, CR | 1 |
| Cartel, JL; Grosset, JH; Guelpa-Lauras, CC; Millan, J | 1 |
| Brown, KE; McDougall, AC; Winsley, BE | 1 |
| Rose, P | 1 |
| Beeching, NJ; Ellis, CJ | 1 |
| Brazin, SA | 1 |
| Ghosh, S; Hazra, SK; McDougall, AC; Yawalkar, SJ | 1 |
| Lang, WR | 1 |
| Fieldsteel, AH; Levy, L | 1 |
| Belehu, A; Haregewoin, A; Mshana, RN | 1 |
| McDougall, AC; Opromolla, DV; Tonello, CJ; Yawalkar, SJ | 1 |
| Bourland, J; Pattyn, SR; Warndorff, J | 1 |
| Chirachariyavej, T; Van Dellen, A | 1 |
| Opl, G; Sighart, H; Weirich, H | 1 |
| Acocella, G | 1 |
| Paul, S; Rose, ET | 1 |
| Seshadri, PS | 1 |
| Anderson, R; Gatner, EM | 1 |
| Gidoh, M; Takitani, S; Tsutsumi, S | 1 |
| Bharadwaj, VP; Desikan, KV; Ramu, G; Venkatesan, K | 1 |
| Britton, WJ; Neupane, K; Soares, DJ | 1 |
| Li, H; Li, T; Weng, X | 1 |
| Chehl, SK; Gelber, RH; Murray, LP; Richard, V; Siu, P; Tsang, M | 1 |
| Bhatia, AS; Katoch, K; Natrajan, M; Yadav, VS | 1 |
| Choudhury, HS; Chowdappa, J; Vasireddi, SS | 1 |
| Ahmed, J; Ahmed, R; Ali, A; Faruque, E; Hoque, AK | 1 |
| Iushchenko, AA; Luzhnova, SA; Urliapova, NG | 1 |
| Lau, G | 1 |
| Arora, PN; Dhaka, RS; Kar, PK; Ramasastry, CV | 1 |
| Dang, DT; Ho, ML; Hoang, TL; Le, TH; Le, TP; Nguyen, DH; Nguyen, DQ; Nguyen, QA; Tran, HK; Vu, TT | 1 |
| Altes-Levy, HR; Chin-a-Lien, RA; Naafs, B | 1 |
| Jackson, T | 1 |
| Blanc, L; Bobin, P; Fayne, OC; Jamet, P; Traore, I | 1 |
| Cartel, JL; Naudin, JC | 1 |
| Bingham, J; Castelino, S; Huengsberg, M; O'Farrell, N; Sherrard, J | 1 |
| Guebre-Xabier, M; Habte-Mariam, HS | 1 |
| Chularatna, W; Mendis, S; Somasiri, KG | 1 |
| Andreoli, A; Kohn, A; Luzi, C; Mangiarotti, R; Prantera, C | 1 |
| Cole, ST; Grosset, J; Honoré, N; Perrani, E; Telenti, A | 1 |
| Oommen, T; Tyagi, PY | 1 |
| Denis, P; Ghys, P; Janssens, L; Karibushi, N; Kuykens, L; Pattyn, SR; Tshilumba, K | 1 |
| Belajouza, C; Denguezli, M; Jomaa, B; Nouira, R; Zili, J | 1 |
| Beena, KR; Kar, HK; Misra, RS; Mukherjee, A; Mukherjee, R; Nair, NS; Parida, SK; Sharma, AK; Walia, R; Zaheer, SA | 1 |
| Duvic, M; Grossman, D; Osborne, B; Rapini, RP | 1 |
| Danziger, LH; Fischer, JH; Hill, C; Occhipinti, DJ; Piscitelli, SC; West, DP | 1 |
| Li, HY | 1 |
| Cartel, JL; Chanteau, S; De Bruyn, J; De Cock, M; Drowart, A; Huygen, K; Launois, P; Van Vooren, JP; Yernault, JC | 1 |
| Britton, WJ; Failbus, SS; Neupane, KD; Roche, PW; Theuvenet, WJ | 1 |
| Shinnick, TM; Van Landingham, RM; Walker, LL | 1 |
| Atrio, N; Columbié, Y; Fernández, AM; González, AB; Hernández, O; Maestre, JL; Martin, M; Rodríguez, J | 1 |
| Lim, JT; Tan, T | 1 |
| Gidoh, M; Saito, H | 1 |
| Ganguly, NK; Kaur, S; Kohli, MM; Sharma, VK | 1 |
| Neuer, A; Spang, E; Sticht-Groh, V | 1 |
| Britton, WJ; Butlin, CR; Failbus, SS; Morgan, A; Neupane, KD | 1 |
| Kaplan, G; Malta, AM; Sampaio, EP; Sarno, EN | 1 |
| Beijnen, JH; Hoetelmans, RM; Koks, CH; Otten, JM; Soesan, M | 1 |
| Chauhan, SL; Girdhar, A; Girdhar, BK; Malaviya, GN; Mishra, B; Venkatesan, K | 1 |
| Cambau, E; Guillemin, I; Jamet, P; Ji, B; Perani, E | 1 |
| Bhargava, P; Kuldeep, CM; Mathur, NK | 1 |
| Antia, NH; Shetty, VP; Uplekar, MW | 1 |
| Bassetti, D; Casazza, R; Cruciani, M; Gatti, G; Hossein, J; Karlsson, M; Merighi, M; Travaini, S | 1 |
| Cottenot, F; de Carsalade, GY; Flageul, B; Pennec, J; Spindler, E; Wallach, D | 1 |
| Pavithran, K; Satish, TC | 1 |
| Gómez Jiménez, G; López Bueno, R; Velázquez de Castro y Sagarra, A | 1 |
| Grosset, JH; Jamet, P; Ji, B; Perani, EG; Sow, S; Traore, I | 1 |
| Carvalho, D; Gouveia, EG; Melchior, E; Queiroz, RH; Souza, AM | 1 |
| Barbosa, JC; de Carvalho, D; de Souza, AM; Gouveia, E; Melchior Júnior, E; Queiroz, RH | 1 |
| Banerji, U; Ganapati, R; Pai, VV; Saha, B; Thomas, J | 1 |
| Bhattacharya, SN; Jain, S; Kumar, S; Sehgal, VN | 1 |
| Casado, JL; Chinchón Lara, I; Creagh, R; Gálvez, J; López-Domínguez, JM; Navarro, A | 1 |
| Ji, B | 1 |
| Arra, GS; Arutla, S; Krishna, DR; Prabhakar, CM | 1 |
| Barral, A; Barral-Netto, M; Bittencourt, AL; Carvalho, EM; Santos, I; Santos, S; von Sohsten, R; Waters, M | 1 |
| Frankel, RI; Maruyama, MH; Ong, AK | 1 |
| Ganapati, R; MacLean, S; Pai, VV; Prange, H; Stietenroth, K | 1 |
| Ahern, KP; Cabrera, A; Levis, WR; Vides, EA | 1 |
| al-Suwaid, AR; Mysore, V | 1 |
| Krishna, KK | 1 |
| Gupte, MD; Habbema, JD; Meima, A; van Oortmarssen, GJ | 1 |
| Kar, HK; Kaur, H; Misra, RS; Mukherjee, A; Mukherjee, R; Rani, R; Sharma, P | 1 |
| Abraham, S; Arunthathi, S; Ebenezer, GJ; Job, A; Job, CK; Rao, PS | 1 |
| Blanc, LJ | 1 |
| Elston, DM; Gilson, RT; Young, RJ | 1 |
| Hsu, S; Winter, CA | 1 |
| Chauhan, DS; Gupta, UD; Katoch, K; Katoch, VM; Natrajan, M; Sharma, RK; Sharma, VD; Singh, D; Singh, HB; Srivastava, K | 1 |
| Smith, CM; Smith, WC | 1 |
| Adedoyin, A; Branch, RA; Frye, RF; Romkes, M; Wilson, JW | 1 |
| Boisseau-Garsaud, AM; Garsaud, P; Helenon, R; Quist, D; Saint-Cyr, I; Vezon, G | 1 |
| John, TJ; Muliyil, J | 1 |
| Balasundaram, B; Ebenezer, G; Natrajan, MM; Rao, GS; Shaw, IN | 1 |
| Barquin, L; Burdick, AE; Elgart, GW; Hendi, A; Scollard, DM | 1 |
| Butlin, CR; Failbus, SS; Neupane, KD; Roche, PW | 1 |
| Middleton, JR; Ranjan, R; Sen, P | 1 |
| Baxt, RD | 1 |
| Christian, M; Jesudasan, K; Kavitha, M; Natrajan, MM; Rao, GS; Shaw, IN | 1 |
| Kashiwabara, Y; Matsuoka, M; Namisato, M | 1 |
| Lockwood, DN; Marlowe, SN | 1 |
| Kalpana, T; Karunakar, N; Krishna, DR; Prabhakar, MC; Reddy, MS | 1 |
| Ramos-e-Silva, M; Rebello, PF | 1 |
| Kapp, A; Kiehl, P; Petering, H; Sticht-Groh, V; Vogelbruch, M; Werfel, T | 1 |
| Janner, D; Prince, JM | 1 |
| Bassetti, C; Siccoli, M | 1 |
| Kalyanina, OV; Luzhnova, SA; Maslov, AK | 1 |
| Alto, WA | 1 |
| Deming, MS; Diomande, I; Djomand, G; Dosso, M; Espey, DK; Gorelkin, L; Horsburgh, CR; Kanga, JM; Marston, BJ; Meyers, WM; Portaels, F; Saki, MZ; Spiegel, RA | 1 |
| Costa Queiroz, RH; de Souza, AM; Melchior, E; Sampaio, SV | 1 |
| Agrawal, US; Meena, RS; Saini, M; Saxena, A; Saxena, V | 1 |
| Lockwood, D | 1 |
| Joyce, MP; Longfield, RN; Murray, CK | 1 |
| Ishii, N; Sasaki, S | 1 |
| Karunakar, N; Krishna, DR; Prabhakar, MC | 1 |
| Christian, M; Jesudasan, K; Kurian, N; Rao, GS; Shaw, IN | 1 |
| Ebenezer, G; Job, CK; Joseph, G; Norman, G; Rao, SP | 1 |
| Horii, N; Ichikawa, E; Ishii, N; Koseki, M; Otsuka, F; Sugita, Y; Tanaka, M | 1 |
| Hawkes, C; Kaplan, K; Zapor, M | 1 |
| Abalos, RM; Balagon, MV; Cellona, RV; Dela Cruz, EC; Fajardo, TT; Tan, EV; Villahermosa, LG; Walsh, DS; Walsh, GP | 1 |
| Alioua, Z; Benomar, S; Boudi, O; Bouzidi, A; Elhaouri, M; Ghfir, M; Sbai, M; Sedrati, OL | 1 |
| Aranda, J; Cohen, JB; Hoang, MP | 1 |
| Abbasi, MA; Fukutomi, Y; Kai, M; Kashiwabara, Y; Khan, MZ; Kobayashi, K; Maeda, S; Maeda, Y; Makino, M; Shah, PA | 1 |
| Joseph, G; Norman, G; Richard, J | 1 |
| Kumarasinghe, MP; Kumarasinghe, SP | 1 |
| Gupta, UD; Katoch, K; Katoch, VM; Natrajan, M; Sharma, VD; Shivanavar, CT | 1 |
| Maeda, S | 1 |
| Gandhi, G; Singh, B | 1 |
| Carvalho, AA; Martins, RS; Siqueira, MG | 1 |
| Chikkamuniyappa, S; Christal, J | 1 |
| Adabag, A; Aslan, O; Batman, C; Citirik, M; Ozalp, S; Zilelioglu, O | 1 |
| Biswas, SK | 1 |
| Alves-Rodrigues, EN; Fontes, CJ; Ribeiro, LC; Silva, MD; Takiuchi, A | 1 |
| Armour, KS; Barnetson, RS; Scolyer, RA | 1 |
| Borges, AS; De Rezende, TM; Ferreira, MS; Goulart, IM; Nishioka, SA; Reis, AC | 1 |
| Helling, CA; Locursio, A; Manzur, ME; Sormani de Fonseca, ML | 1 |
| Alves-Rodrigues, EN; Fontes, CJ; Martini-Filho, D; Rabel-Filho, OC; Ribeiro, LC; Silva, MD; Takiuchi, A | 1 |
| Bahloul, Z; Feki, I; Jlidi, R; Mhiri, C; Miladi, MI | 1 |
| Roca, B | 1 |
| Ho, CK; Lo, KK | 1 |
| Dayal, R; Kamal, R; Katoch, K; Katoch, VM | 1 |
| Gidoh, M; Goto, M; Hatano, K; Ishida, Y; Ishii, N; Nogami, R; Okano, Y; Ozaki, M | 1 |
| Matsuoka, M; Suzuki, Y | 1 |
| Lam, DS; Liu, DT; Yuen, HK | 1 |
| Firooz, A | 1 |
| Burns, J | 1 |
| Arif, MA; Manglani, PR | 1 |
| Mahajan, VK; Sharma, NL | 1 |
| Courtright, P; Lewallen, S | 1 |
| Arora, SK | 1 |
| Flageul, B; Gaulier, A; Ighilahriz, O; Ingen-Housz-Oro, S; Levy-Weil, F; Meyer, M; Sigal-Grinberg, M; Wendling, J | 1 |
| Birshner, Rde C; Deps, PD; Guerra, P; Nasser, S; Rodrigues, LC; Simon, M | 1 |
| Al Attia, HM | 1 |
| Illarramendi, X; Jardim, MR; Nascimento, OJ; Nery, JA; Sales, AM; Sampaio, EP; Sarno, EN | 1 |
| Cabrera, A; Giovinazzo, J; Glickman, MS; Levis, WR; Martiniuk, F; Rao, SD; Rea, TH; Rom, WN | 1 |
| Concha R, M; Cossio T, ML; Fich S, F; González B, S; Pérez C, C; Salazar S, I | 1 |
| Angel-Moreno, A; Ramos, A; Roustán, G; Suárez, E | 1 |
| Gupte, MD; Htoon, MT; Jadhav, V; Jamesh, A; Jianping, S; Katoch, K; Krishnamurthy, P; Kroger, A; Manickam, P; Pannikar, V; Ramalingam, K | 1 |
| Beltrán, C; Cardona-Castro, N; Gómez, Y; Hernández, E; Kimura, M; Rodríguez, G; Villegas, S; Vissa, VD | 1 |
| Abide, JM; Jones, HL; Webb, RM; Young, L | 1 |
| Catorze, MG; Medeiros, S; Vieira, MR | 1 |
| Aricò, M; Bongiorno, MR; Noto, S; Pistone, G | 1 |
| Andre, P; Camu, W; Flageul, B; Gabelle, A; Vallat, JM | 1 |
| Arenas, R; Asz-Sigall, D; López-García, L; Neme-Yunes, Y; Vega-Memije, ME; Yuen-Palos, R | 1 |
| Boyé, T; Carli, P; Carsuzaa, F; Graffin, B; Landais, C; Leyral, G | 1 |
| Beylot, C; Ezzedine, K; Longy-Boursier, M; Malvy, D | 1 |
| Dytoc, M; Kalisiak, M; Yeung, R | 1 |
| Manifold, R; Marshman, G | 1 |
| Gatt, P; Jacobson, RR | 1 |
| Pandey, B; Sapkota, BR; Shrestha, K; Walker, SL | 1 |
| Ozaki, M | 1 |
| Singh, RK | 1 |
| Bassi, J; Garg, A; Gulati, AK; Singh, S; Tilak, R; Tilak, V | 1 |
| Antunes, CM; Borges, VO; Bretas, TL; Costa, RD; Lyon, S; Mendonça, VA; Penido, RA; Teixeira, AL; Teixeira, MM | 1 |
| Becker, L; Kowalewski, C; Martin, JM | 1 |
| Guedes Filho, G; Guedes, WR; Oliveira, BB; Oliveira, CA; Oliveira, DA; Silva, IM | 1 |
| Ali, K; Malik, MA; Sittampalam, G | 1 |
| Gómez-Bernal, S; Rodríguez-Pazos, L; Sánchez-Aguilar, D; Toribio, J | 1 |
| Arvind, C; Sheetal, S | 1 |
| Abalos, RM; Balagon, MF; Cellona, RV; Gelber, RH; Saunderson, PR | 1 |
| Hall, JM; Kahn, MA; Moreland, AA; Moschella, SL; Torske, KR | 1 |
| Ladizinski, B; Levis, WR; Spencer, TI | 1 |
| Agarwal, V; Chauhan, S; Wakhlu, A | 1 |
| Carreño-Martinez, C; Fafutis-Morris, M; Fukushima, Y; Garcia, IE; Matsuoka, M; Nakajima, C; Suzuki, Y; Vargas-González, A | 1 |
| Badiane, CI; Batista, G; Bazolo, N; Guèye, NF; Manga, NM; Poda, A; Sané, O; Sow, PS | 1 |
| Dillig, G; Feldman, J; Ida, J; Negrete, V; Zohrabian, N | 1 |
| Amin, SS; Bansal, S; Khan, Z; Sachdeva, S; Sharma, PK | 1 |
| Dey, V; Dulhani, N; Nel, B; Singh, H; Tiwari, P | 1 |
| Arunagiri, K; Kumar, BN; Menaka, K; Narayanan, S; Oommen, PK; Sekar, B | 1 |
| Balagon, M; Maghanoy, A; Mallari, I; Saunderson, P | 1 |
| Abalos, RM; Balagon, M; Cellona, RV; Ravanes, JM; Walsh, DS; Walsh, GP | 1 |
| Balagon, M; Brennan, PJ; Dela Pena, EL; Li, W; Lyons, DE; Maghanoy, AA; Mallari, IB; Nath, I; Orcullo, FM; Sakamuri, RM; Shinde, V; Tan, EV; Vissa, V | 1 |
| Dacso, MM; Jacobson, RR; Prestigiacomo, JF; Scollard, DM; Stryjewska, BM | 1 |
| Crosti, C; Cusini, M; Marzano, AV; Massone, C; Nunzi, E; Tosi, D | 1 |
| Aftab, H; Bygbjerg, IC; Due, E; Nielsen, SD; Nielsen, SL; Thybo, S | 1 |
| Dofitas, BL; Yuchua-Guillen, A | 1 |
| Chakma, JK; Girdhar, A; Hussein, S; Malaviya, GN | 1 |
| Ishii, N; Makino, M; Mori, S; Suzuki, K; Yotsu, RR | 1 |
| Adar, T; Barak, O; Mizrahi, M; Shalit, M; Tavdi, S; Tayer-Shifman, O | 1 |
| Akama, T; Degang, Y; Gidoh, M; Hara, T; Ishido, Y; Ishii, N; Makino, M; Suzuki, K; Tanigawa, K | 1 |
| Almeida, PC; Bührer-Sékula, S; Cruz, R; Gonçalves, Hde S; Moraes, ME; Penna, GO; Pontes, MA | 1 |
| Cunha, Mda G; Lockwood, DN | 1 |
| Avelleira, JC; Campos, AA; Cruz, RC; Cunha, Mda G; Filho, B; Ghuidella, C; Schettini, AP; Ura, S; Viana, Fdos R; Virmond, M | 1 |
| Deps, P; Guerra, P; Nasser, S; Simon, M | 1 |
| Göttig, S; Weberschock, T | 1 |
| Benchikhi, H; Chiheb, S; Hali, F; Rifki, A; Tirhazouine, I | 1 |
| Ker, KJ; Lui, NL; Pan, JY; Tey, HL | 1 |
| Levin, NA; Makredes, M; O'Donnell, P; Yang, S | 1 |
| Gillis, TP; Keas, S; Lewis, C; Robbins, N; Sandoval, FG; Scollard, DM; Williams, DL | 1 |
| Batista Júnior, J; Borges, RS; Coleman, MD; Monteiro, MC; Oliveira, FR; Romão, PR; Salgado, CG; Schalcher, TR; Vieira, JL | 1 |
| Ait Ourhroui, M; El Morabite, K; Hassam, B; Senouci, K; Tbatou, F | 1 |
| Abhinav, C; Chander, B; Chauhan, PS; Khatri, G; Mahajan, VK; Mehta, KS; Prabha, N; Sharma, SK; Sharma, V; Tuli, R | 1 |
| Colorado, CL; Guerrero, MI; León, CI; Torres, JF | 1 |
| Kai, M | 1 |
| Conerly, S; Marcos, LA; Walker, S | 1 |
| Li, J; Shen, J; Yan, L; Yu, M; Yu, X; Zhang, G | 1 |
| Agrawal, S; Bumb, RA; Khandelwal, K; Oghumu, S; Salotra, P; Satoskar, AR | 1 |
| Chang, ZQ; Li, J; Zhai, QQ | 1 |
| Afzalimoghadam, M; Daneshbod, Y; Eilami, O; Mirfazaelian, H | 1 |
| Chen, M; Fu, X; Liu, D; Liu, H; Sun, Y; Wang, C; Wang, J; Yu, X; Zhang, F; Zhang, Q; Zhang, Y; Zhou, G | 1 |
| Avancini, J; Guariento, A; Lopes, VA; Lourenço, DM; Silva, CA; Trindade, MA | 1 |
| Amati, A; Foschini, MP; Giannoccaro, MP; Liguori, R; Parodi, A; Terlizzi, R; Valentino, ML | 1 |
| Fu, X; Liu, H; Zhang, F | 1 |
| Han, XY; Quintanilla, M | 1 |
| Aubry, A; Cambau, E; Reibel, F | 1 |
| Kim, JS; Kwon, SH; Shin, JY | 1 |
| Fabbrocini, G; Forgione, P; Romagosa, R; Romanelli, P; Villada, G; Zarei, M | 1 |
| Cardoso, J; Coelho de Sousa, V; Laureano, A | 1 |
| Ozturk, Z; Tatliparmak, A | 1 |
| Moraes, MO | 1 |
| Avanzi, C; Benjak, A; Busso, P; Camara, I; Cole, ST; Doumbia, G; Drame, T; Fomba, A; Johnson, RC; Kodio, M; Lamou, A; Loiseau, C; Sakho, F; Sock, G; Sow, SO | 1 |
| Beltrán-Alzate, C; Brennan, P; Cardona-Castro, N; Kimura, M; Li, W; López Díaz, F; Romero-Montoya, M; Sakamuri, R | 1 |
| Bharucha, T; Lockwood, D | 1 |
| Gupte, MD; Jadhav, V; Jamesh, A; Jianping, S; Kaliaperumal, K; Katoch, K; Krishnamurthy, P; Kutaiyan, R; Manickam, P; Mehendale, SM; Mugudalabetta, S; Nagaraju, B; Padma, J; Pannikar, V; Rajkumar, P | 1 |
| Benard, G; de Paula, FJ; Duarte, AJDS; Lemos, FBC; Sakai-Valente, NY; Trindade, MAB; Vieira, AP | 1 |
| Lurati, AR | 1 |
| Araujo, S; Fontes, AB; Goulart, IMB; Goulart, LR; Li, W; Matsuoka, M; Rosa, PS; Scollard, DM; Suffys, P; Truman, RW; Vissa, V; Williams, DL | 1 |
| Aerts, A; Kawuma, J; Kita, E; Saunderson, P; Smith, CS; Virmond, M | 1 |
| Barreto, ML; Bührer-Sékula, S; Costa, MB; Cruz, R; de Andrade, ARC; de Araújo, MG; Gonçalves, HS; Kerr, LRS; Penna, GO; Penna, MLF; Pontes, MAA; Ramos, AMC; Rodrigues, LC; Rosa, PS; Stefani, MMA | 1 |
| Bass, M; Foster, K; Studdiford, J | 1 |
| Fischer, M | 1 |
| Anderson, KL; Karai, LJ; Minni, JP; Nowak, MA; Sanik, E | 1 |
| Boggild, AK; Bonnar, PE; Cunningham, NP; Davis, IRC; Sharma, R; Walsh, NM | 1 |
| Dhakre, VW; Prasad, A; Samdani, P; Shah, PM | 1 |
| Cambau, E; Cardona-Castro, N; Cauchoix, B; Cole, ST; Cooreman, EAWD; Gillini, L; Gupta, UD; Hagge, D; Hongseng, W; Indropo, A; Johnson, RC; Kai, M; Lavania, M; Matsuoka, M; Miyamoto, Y; Pannikar, VK; Pemmaraju, VRR; Rosa, PS; Saunderson, P; Srikantam, A; Suffys, P; Vissa, V; Williams, D | 1 |
| Daga, S; Kumavat, S; Pawar, M; Zawar, V | 1 |
| Gradzielski, M; Kanwar, R; Mehta, SK | 1 |
| Bührer-Sékula, S; Cruz, RCDS; Gonçalves, HS; Moraes, MEA; Penna, GO; Penna, MLF; Pontes, MAA; Stefani, MMA; Talhari, S | 1 |
| Stock, I | 1 |
| Araujo, S; Scollard, D; Stryjewska, BM; Williams, DL | 1 |
| Kofler, L; Müller, A; Wolfsperger, F; Yazdi, AS | 1 |
| da Costa Nery, JA; Pereira Cardozo, MR; Tavares Rodrigues, F | 1 |
| Awali, R; Chandrasekar, PH | 1 |
| Cataño, JC; Giraldo, DE | 1 |
| Bao, F; Cao, J; Cao, Q; Chai, Z; Chen, S; Cheng, X; Chu, T; Duan, Q; Fu, F; Fu, X; Irwanto, A; Ke, W; Krismawati, H; Kuang, Y; Lang, X; Li, J; Li, L; Li, M; Li, W; Lin, Z; Liu, D; Liu, H; Liu, J; Liu, Q; Mi, Z; Ning, Y; Pan, Q; Shang, X; Shen, J; Shen, Y; Sun, L; Sun, Y; Wang, C; Wang, H; Wang, L; Wang, X; Wang, Y; Wang, Z; Wu, W; Xiao, B; Xiao, P; Xiong, F; Xiong, J; Xiong, L; Xiong, M; Xu, Y; Yan, L; Yang, B; Yang, J; You, J; Yu, G; Yu, W; Yue, Z; Zhan, X; Zhang, F; Zhang, G; Zhang, H; Zhang, L; Zhang, Y; Zhao, Q; Zhao, W; Zheng, H | 1 |
| Duran Merino, CE; Jaramillo, MJ; Ortiz Úsuga, MC; Rodríguez, AM | 1 |
| George, J | 1 |
| An, HK; Kivela, P; Lee, JH; Oh, S; Sohn, MG | 1 |
| Huang, HW; Lee, CH; Lin, SH | 1 |
| Bidari-Zerehpoosh, F; Bizaval, Z; Mozafari, N; Niknejad, N; Robati, RM | 1 |
| Irwan, ID; Irwanto, A; Krismawati, H; Liu, H; Liu, J; Maladan, Y; Oktavian, A; Pongtiku, A; Sitanggang, YA; Sun, Y; Tanjung, R; Wahyuni, T; Zhang, F | 1 |
| Hacker, MAVB; Illarramendi, X; Maia, RC; Moraes, MO; Nery, JAC; Sales, AM; Sarno, EN | 1 |
| Biswas, A; Chakraborty, A; Ghosh, R | 1 |
| Chew, R; Woods, ML | 1 |
| Andrade, ESN; Araújo, WN; Brandão, JG; Coriolano, CRF; Ferreira, CO; Gomes, CM; Moraes, MO; Rosa, PS; Silva, JSD | 1 |
| Egeberg, A; Frew, JW; Ingram, JR; Maul, JT; Nielsen, ML; Ring, HC; Thomsen, SF; Thorsen, J; Thyssen, JP; Wu, JJ; Yao, Y | 1 |
| Ahuja, M; Darlong, J; Hembrom, S; Lavania, M; Pathak, VK; Sengupta, U; Singh, I; Singh, SV; Turankar, RP | 1 |
| Assoumani, Y; Aubry, A; Baco, A; Cambau, E; de Jong, BC; Hasker, E; Jouet, A; Lenoir, E; Marijke Braet, S; Mzembaba, A; Rigouts, L; Suffys, PN; Supply, P; Van Dyck-Lippens, M; Vasconcellos, SEG | 1 |
| Jin, G; Li, G; Li, X; Li, Y; Shao, Y; Wei, P; Yang, J; Zhang, L | 1 |
| Ahuja, M; Khurana, A; Muddebihal, A; Sachdeva, S; Sardana, K; Sharma, R; Singh, I | 1 |
| Bao, F; Chen, J; Dong, Y; Fan, Y; Gao, L; Ji, Z; Kong, J; Li, B; Liu, A; Liu, M; Luo, S; Ma, W; Peng, L; Song, J; Wu, X; Yang, J | 1 |
| Chhabra, S; Dogra, S; Jain, S; Kaur, M; Minz, RW; Nadeem, M; Narang, T; Pandey, P; Sahu, S; Sharma, A; Sharma, K; Sharma, R; Shilpa, S; Singh, I; Yadav, R | 1 |
43 review(s) available for dapsone and rifampin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Chemotherapy in Leprosy.
Topics: Acetamides; Anemia, Hemolytic; Aniline Compounds; Animals; Clofazimine; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprosy; Methimazole; Mice; Mycobacterium leprae; Phenyl Ethers; Rifampin; Sulfonamides; Thiosemicarbazones; Thiourea | 1975 |
Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational proced
Topics: Clofazimine; Dapsone; Epidemiologic Methods; Ethiopia; Humans; Incidence; Leprostatic Agents; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Recurrence; Rifampin | 1992 |
Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Topics: Dapsone; Drug Therapy, Combination; Ethiopia; Humans; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Patient Compliance; Rifampin; Time Factors; World Health Organization | 1992 |
Drug interactions: part II.
Topics: Amiodarone; Biological Availability; Dapsone; Didanosine; Drug Interactions; Fluconazole; Food; Humans; Intestinal Absorption; Ketoconazole; Pharmaceutical Preparations; Rifampin | 1992 |
Pharmacochemical aspects of leprosy. Recent developments and prospects for new drugs.
Topics: Dapsone; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin | 1989 |
Leprosy presenting as peripheral neuropathy.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Male; Peripheral Nervous System Diseases; Rifampin | 1988 |
Chemotherapy of leprosy.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Rifampin | 1988 |
Screening of drugs for activity against Mycobacterium leprae.
Topics: Animals; Clofazimine; Dapsone; Drug Evaluation, Preclinical; Leprostatic Agents; Leprosy; Mice; Mycobacterium leprae; Rifampin; Thioamides | 1987 |
Pharmacokinetics in drug screening.
Topics: Animals; Biological Availability; Body Weight; Dapsone; Drug Evaluation, Preclinical; Humans; Leprostatic Agents; Leprosy; Ofloxacin; Oxazines; Rifampin; Species Specificity | 1987 |
Drug resistance in leprosy--a review.
Topics: Animals; Clofazimine; Dapsone; Drug Resistance, Microbial; Ethionamide; Humans; Leprosy; Mice; Microbial Sensitivity Tests; Rifampin | 1985 |
Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae.
Topics: Aniline Compounds; Dapsone; Drug Resistance, Microbial; Ethionamide; Humans; Leprosy; Mycobacterium leprae; Phenazines; Rifampin; Sulfonamides; Sulfones; Thioacetazone; Thiosemicarbazones; Thiourea | 1973 |
Growing points in leprosy research. 4. Recent advances in the chemotherapy of leprosy.
Topics: Clofazimine; Dapsone; Ethionamide; Humans; Leprosy; Rifampin; Sulfonamides; Thioacetazone; Thiourea | 1974 |
The first decade in experimental leprosy.
Topics: Animals; BCG Vaccine; Clofazimine; Dapsone; Disease Models, Animal; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; Leprosy; Mice; Mycobacterium leprae; Radiation Effects; Rifampin; Thymectomy | 1971 |
Evolution of the modern chemotherapy of leprosy.
Topics: Animals; Clofazimine; Dapsone; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Recurrence; Rifampin | 1983 |
Recent changes in leprosy control.
Topics: Bacterial Vaccines; Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Rifampin; World Health Organization | 1983 |
The immunopharmacology of antileprosy agents.
Topics: Antigens, Bacterial; Clofazimine; Dapsone; Erythema Nodosum; Humans; Immune Tolerance; Immunity, Cellular; Leprostatic Agents; Leprosy; Lymphocyte Activation; Mycobacterium leprae; Neutrophils; Rifampin | 1983 |
Leprosy (Hansen's disease).
Topics: Clofazimine; Dapsone; Ear Deformities, Acquired; Humans; Leprosy; Mouth Diseases; Nose Deformities, Acquired; Rifampin; Thalidomide | 1982 |
[Present status of studies on antileprosy drugs].
Topics: Animals; Clarithromycin; Dapsone; Drug Therapy, Combination; Humans; Immunologic Factors; Leprostatic Agents; Minocycline; Prothionamide; Quinolones; Rifampin; Rifamycins; Thalidomide | 1995 |
Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy.
Topics: Acedapsone; Clinical Trials as Topic; Cost-Benefit Analysis; Dapsone; Humans; Leprostatic Agents; Leprosy; Rifampin; Risk Factors; Topography, Medical | 2000 |
Update on leprosy.
Topics: Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Peripheral Nervous System Diseases; Rifampin | 2001 |
Leprosy.
Topics: Clofazimine; Cost-Benefit Analysis; Dapsone; Drug Therapy, Combination; Global Health; Humans; International Cooperation; Leprostatic Agents; Leprosy; Mycobacterium Infections; Mycobacterium leprae; Prevalence; Rifampin; World Health Organization | 2001 |
Leprosy. Recognition and treatment.
Topics: Adolescent; Adult; Age Factors; Biopsy; Child; Clinical Trials as Topic; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Multicenter Studies as Topic; Peripheral Nerves; Rifampin; Skin; Time Factors; World Health Organization | 2001 |
Leprosy.
Topics: Bacterial Vaccines; BCG Vaccine; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium leprae; Rifampin | 2002 |
[Leprosy].
Topics: Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Prognosis; Rifampin; World Health Organization | 2003 |
[Histoid leprosy with erythema nodosum leprosum].
Topics: Adult; Clofazimine; Dapsone; Erythema Nodosum; Fluoroquinolones; Histiocytes; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium leprae; Rifampin | 2003 |
[DNA microarray based rapid drug susceptibility test for Mycobacterium leprae].
Topics: Animals; Dapsone; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Ofloxacin; Oligonucleotide Array Sequence Analysis; Rifampin | 2006 |
Therapeutic options for cutaneous leishmaniasis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Dapsone; Humans; Imidazoles; Leishmaniasis, Cutaneous; Rifampin | 2007 |
A overview of ocular leprosy after 2 decades of multidrug therapy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Eye Infections, Bacterial; Global Health; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin | 2007 |
[Hansen's disease: case report and review of literature].
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Treatment Outcome | 2008 |
Arthritis in leprosy.
Topics: Arthritis; Clofazimine; Dapsone; Diagnosis, Differential; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin | 2010 |
Update on the epidemiology, diagnosis, and treatment of leprosy.
Topics: Antibodies, Bacterial; Bacteriological Techniques; Biopsy; Clofazimine; Dapsone; Drug Resistance, Bacterial; Drug Utilization; Genome, Bacterial; Global Health; History, 16th Century; History, 17th Century; History, 18th Century; History, Ancient; Humans; Leprostatic Agents; Leprosy; Molecular Diagnostic Techniques; Mycobacterium leprae; Phylogeny; Prevalence; Rifampin; Risk Factors | 2015 |
Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
Topics: Adult; Breast Feeding; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Leprosy, Multibacillary; Pregnancy; Pregnancy Complications, Neoplastic; Rifampin; Time Factors; Treatment Outcome | 2017 |
An Employee With Undiagnosed Leprosy: Are Other Employees at Risk?
Topics: Dapsone; Diagnosis, Differential; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Occupational Health Nursing; Rifampin | 2017 |
Multidrug therapy for leprosy: a game changer on the path to elimination.
Topics: Clofazimine; Dapsone; Disease Eradication; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin | 2017 |
Leprosy - an overview of clinical features, diagnosis, and treatment.
Topics: Adult; Aged; Child; Clofazimine; Cross-Sectional Studies; Dapsone; Disease Progression; Drug Administration Schedule; Female; Guideline Adherence; Humans; Immunity, Cellular; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Long-Term Care; Male; Neglected Diseases; Rifampin | 2017 |
Leprosy – an old infectious disease with unsolved matters.
Topics: Animals; Armadillos; Clofazimine; Cross-Sectional Studies; Dapsone; Disease Reservoirs; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 2016 |
Chronic Unilateral Uveitis as a Manifestation of Leprosy: A Case Report and Literature Review.
Topics: Aged; Atrophy; Biopsy; Chronic Disease; Clofazimine; Dapsone; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Iris; Leprostatic Agents; Leprosy, Lepromatous; Macular Edema; Male; Mycobacterium leprae; Rifampin; Skin; Tomography, Optical Coherence; Uveitis, Anterior | 2021 |
Metabolism and interactions of antileprosy drugs.
Topics: Acedapsone; Biological Availability; Biotransformation; Clofazimine; Cytochrome P-450 CYP3A; Dapsone; Drug Interactions; Drug Therapy, Combination; Half-Life; Humans; Leprostatic Agents; Leprosy; Metabolic Clearance Rate; Metabolic Networks and Pathways; Mycobacterium leprae; Rifampin | 2020 |
Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.
Topics: Amino Acids; Dapsone; Drug Resistance, Bacterial; Humans; Leprostatic Agents; Leprosy; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Ofloxacin; Rifampin | 2022 |
Seventy years of evidence on the efficacy and safety of drugs for treating leprosy: a network meta-analysis.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Leprosy, Multibacillary; Network Meta-Analysis; Rifampin | 2023 |
78 trial(s) available for dapsone and rifampin
| Article | Year |
|---|---|
Clinical trial with rifampicin in the treatment of leprosy (final report).
Topics: Clinical Trials as Topic; Dapsone; Leprosy; Rifampin; Time Factors | 1977 |
Rifampicin for lepromatous leprosy: nine years' experience.
Topics: Animals; Clinical Trials as Topic; Dapsone; Drug Combinations; Humans; Leprosy; Mice; Mycobacterium leprae; Phenylthiourea; Rifampin | 1978 |
Introductory rifampicin therapy in lepromatous leprosy: a six month follow-up study.
Topics: Clinical Trials as Topic; Dapsone; Double-Blind Method; Follow-Up Studies; Humans; Leprosy; Male; Rifampin | 1978 |
A statistical analysis of two chemotherapy trials in lepromatous leprosy. I. The response to therapy as measured by inoculation of mice.
Topics: Adolescent; Adult; Aged; Animals; Clinical Trials as Topic; Clofazimine; Dapsone; Female; Humans; Leprosy; Male; Mice; Middle Aged; Mycobacterium leprae; Regression Analysis; Rifampin; Skin | 1978 |
A statistical analysis of two chemotherapy trials in lepromatous leprosy. II. Interactions among patient variables.
Topics: Adolescent; Adult; Age Factors; Aged; Cell Count; Clinical Trials as Topic; Clofazimine; Dapsone; Female; Humans; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Sex Factors; Skin; Statistics as Topic | 1978 |
Evaluation of treatment of lepromatous leprosy patients in the Netherlands.
Topics: Clinical Trials as Topic; Clofazimine; Dapsone; Drug Evaluation; Humans; Leprostatic Agents; Leprosy; Netherlands; Phenylthiourea; Recurrence; Rifampin; Time Factors | 1979 |
Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Middle Aged; Mycobacterium leprae; Nasal Mucosa; Rifampin; Skin | 1979 |
'Pulsed' rifampicin therapy in leprosy. A clinical study.
Topics: Adolescent; Adult; Clinical Trials as Topic; Dapsone; Humans; Leprosy; Nasal Septum; Rifampin; Skin; Time Factors | 1979 |
Short course two months treatment of paucibacillary leprosy with rifampicin. Preliminary results.
Topics: Adolescent; Adult; Clinical Trials as Topic; Dapsone; Female; Humans; Leprosy; Male; Rifampin | 1979 |
[Treatment of open cavernous pulmonary tuberculosis (author's transl)].
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Rifampin; Tuberculosis, Pulmonary | 1979 |
Clinical trial with rifampicin in the treatment of leprosy.
Topics: Adolescent; Adult; Clinical Trials as Topic; Dapsone; Female; Humans; Leprosy; Male; Middle Aged; Rifampin | 1976 |
Rifampin therapy of lepromatous leprosy.
Topics: Acetamides; Animals; Clinical Trials as Topic; Dapsone; Drug Administration Schedule; Erythema Nodosum; Humans; Leprosy; Mice; Microbial Sensitivity Tests; Mycobacterium leprae; Philippines; Recurrence; Rifampin; Sulfones; Time Factors | 1975 |
Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.
Topics: Acetamides; Adolescent; Adult; Aged; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Dapsone; Dosage Forms; Female; Humans; Infant; Leprostatic Agents; Leprosy; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium leprae; New Guinea; Recurrence; Remission, Spontaneous; Rifampin; Time Factors | 1975 |
A controlled clinical trial of continuous and intermittent rifampicin therapy during an initial three months period in lepromatous leprosy: final analysis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clofazimine; Dapsone; Female; Humans; Leprosy; Male; Middle Aged; Rifampin; Time Factors | 1975 |
Combined therapy in leprosy.
Topics: Adult; Clinical Trials as Topic; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin | 1975 |
Treatment of leprosy with rifampicin and isoprodian (L73A).
Topics: Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Prothionamide; Rifampin | 1975 |
Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
Topics: Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Mycobacterium leprae; Prothionamide; Rifampin | 1975 |
Rifampicin and isoprodian in combination in the treatment of leprosy.
Topics: Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Malta; Prothionamide; Rifampin | 1975 |
Preliminary experience with rifampicin and isoprodian (L73A)--combination in lepromatous leprosy.
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Leprosy; Male; Middle Aged; Prothionamide; Rifampin | 1975 |
Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothionamide; Rifampin | 1975 |
Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
Topics: Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethiopia; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Prothionamide; Rifampin | 1975 |
Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Dapsone; Double-Blind Method; Drug Combinations; Female; Humans; Incidence; Isoniazid; Leprostatic Agents; Leprosy, Lepromatous; Liver Function Tests; Male; Middle Aged; Prospective Studies; Prothionamide; Rifampin | 1992 |
A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin with a single dose of rifampicin followed by one year of daily dapsone. The Collaborative Study Group for the Treatment of Leprosy in Zaire.
Topics: Dapsone; Democratic Republic of the Congo; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Prospective Studies; Recurrence; Rifampin; Skin | 1991 |
Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Isoniazid; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Randomized Controlled Trials as Topic; Rifampin | 1990 |
Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy.
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium leprae; Prospective Studies; Random Allocation; Recurrence; Remission Induction; Rifampin | 1990 |
Multidrug therapy for treatment of paucibacillary leprosy in western Kenya--preliminary communications.
Topics: Adolescent; Adult; Child; Child, Preschool; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Kenya; Leprosy; Male; Middle Aged; Prospective Studies; Rifampin; Sex Factors; Time Factors | 1990 |
Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment.
Topics: Adolescent; Adult; Dapsone; Drug Combinations; Drug Resistance; Humans; Isoniazid; Leprosy; Recurrence; Rifampin; Sex Factors; Thioacetazone | 1985 |
Pyrazinamide as a part of combination therapy for BL and LL patients--a preliminary report.
Topics: Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprosy; Male; Mice; Middle Aged; Muscle, Smooth; Pyrazinamide; Rifampin; Scrotum; Skin; Thioacetazone | 1988 |
Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
Topics: Clinical Trials as Topic; Clofazimine; Cohort Studies; Dapsone; Drug Administration Schedule; Ethionamide; Female; Humans; Leprostatic Agents; Leprosy; Male; Rifampin | 1989 |
Combined regimens of one year duration in the treatment of multibacillary leprosy--II. Combined regimens with rifampicin administered during 6 months.
Topics: Clinical Trials as Topic; Clofazimine; Cohort Studies; Dapsone; Drug Administration Schedule; Ethionamide; Female; Humans; Leprostatic Agents; Leprosy; Male; Rifampin | 1989 |
Random variation in tuberculin sensitivity in schoolchildren. Serial skin testing before and after preventive treatment for tuberculosis.
Topics: Adolescent; Child; Dapsone; Drug Combinations; Ethambutol; Female; Humans; Hypersensitivity, Delayed; Isoniazid; Male; Placebos; Prothionamide; Random Allocation; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1989 |
Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide.
Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Prothionamide; Pyrazinamide; Radiography; Recurrence; Rifampin; Sputum; Tuberculosis, Pulmonary | 1987 |
A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin followed by 1 year of daily dapsone with 10 weekly doses of rifampicin.
Topics: Clinical Trials as Topic; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Prospective Studies; Random Allocation; Rifampin | 1987 |
Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
Topics: Animals; Dapsone; Drug Therapy, Combination; Humans; Immune Tolerance; Immunosuppression Therapy; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Rats; Rats, Inbred Lew; Rifampin; Thymectomy; Thymus Gland | 1986 |
Efficacy of different regimens in multibacillary leprosy.
Topics: Clinical Trials as Topic; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Ethionamide; Humans; Leprosy; Random Allocation; Rifampin | 1986 |
Comparison of DDS with two combined chemotherapy regimens for multibacillary leprosy. Results after 3 years of treatment. A prospective randomized multicentre study.
Topics: Adult; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Prospective Studies; Prothionamide; Random Allocation; Rifampin | 1986 |
Further experience with the rapid bactericidal effect of rifampin on Mycobacterium leprae.
Topics: Animals; Biopsy; Clinical Trials as Topic; Dapsone; Dose-Response Relationship, Drug; Humans; Leprosy; Mice; Mycobacterium leprae; Rifampin; Time Factors | 1974 |
Experimental and clinical studies on rifampicin in treatment of leprosy.
Topics: Animals; Clinical Trials as Topic; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mice; Mycobacterium leprae; Rifampin | 1970 |
Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosy.
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Methods; Middle Aged; Random Allocation; Rifampin | 1982 |
THELEP controlled clinical trials in lepromatous leprosy.
Topics: Animals; Clinical Trials as Topic; Clofazimine; Dapsone; Female; Humans; Leprostatic Agents; Leprosy; Male; Mice; Prothionamide; Rifampin | 1983 |
[Field experiences with therapy protocols in leprosy].
Topics: Clinical Trials as Topic; Clofazimine; Dapsone; Drug Administration Schedule; Humans; Leprostatic Agents; Leprosy; Prospective Studies; Rifampin | 1983 |
Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Female; Humans; Leprosy; Male; Middle Aged; Prospective Studies; Rifampin | 1984 |
[Initial results of prospective controlled treatment trials in leprosy].
Topics: Adolescent; Adult; Clinical Trials as Topic; Dapsone; Female; Humans; Leprosy; Male; Middle Aged; Prospective Studies; Random Allocation; Rifampin; Time Factors | 1984 |
Multidrug therapy for leprosy in Trinidad and Tobago: a preliminary report.
Topics: Acedapsone; Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Leprosy; Male; Middle Aged; Rifampin; Trinidad and Tobago | 1984 |
Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Rifampin | 1981 |
Intermittent rifampicin therapy in lepromatous leprosy.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Clinical Trials as Topic; Dapsone; Double-Blind Method; Drug Therapy, Combination; Erythema Nodosum; Humans; Leprosy; Mice; Mitotic Index; Mycobacterium leprae; Rifampin; Time Factors | 1980 |
A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Clinical Trials as Topic; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Middle Aged; Rifampin; Skin | 1981 |
[Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].
Topics: Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Male; Middle Aged; Prothionamide; Pyrazinamide; Radiography; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1982 |
Paucibacillary leprosy patients treated with multidrug therapy four years experience (1988 to 1991) in Bangladesh.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bangladesh; Child; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprosy; Male; Middle Aged; Rifampin | 1994 |
Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy.
Topics: Agglutination Tests; Antibodies, Bacterial; Antigens, Bacterial; Clofazimine; Dapsone; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Cellular; Immunoglobulin M; Immunoglobulins; Leprostatic Agents; Leprosy; Longitudinal Studies; Lymphocyte Activation; Mycobacterium leprae; Rifampin; Skin Tests | 1994 |
Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clofazimine; Crohn Disease; Dapsone; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium Infections, Nontuberculous; Prospective Studies; Rifampin; Time Factors | 1994 |
A randomized clinical trial of two single-dose treatments for paucibacillary leprosy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Ethionamide; Female; Humans; Infant; Leprosy; Male; Middle Aged; Prognosis; Recurrence; Rifampin | 1994 |
Reversal reaction in multibacillary leprosy patients following MDT with and without immunotherapy with a candidate for an antileprosy vaccine, Mycobacterium w.
Topics: Bacterial Vaccines; Clofazimine; Combined Modality Therapy; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Neuritis; Rifampin; Single-Blind Method | 1993 |
Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Humans; Interferon-gamma; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Mycobacterium leprae; Recombinant Proteins; Rifampin; Skin; Thalidomide | 1996 |
Population pharmacokinetics of dapsone administered biweekly to human immunodeficiency virus-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agents; Antibiotics, Antitubercular; Dapsone; Drug Interactions; Female; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Rifampin | 1996 |
Daily multidrug therapy for leprosy; results of a fourteen-year experience.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Erythema Nodosum; Ethionamide; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Middle Aged; Recurrence; Rifampin | 1997 |
High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Ofloxacin; Recurrence; Rifampin | 1997 |
Influence of acetylator phenotype on the haematological and biochemical effects associated with dapsone in leprosy patients.
Topics: Blood Cell Count; Blood Chemical Analysis; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase; Humans; Leprostatic Agents; Leprosy; Male; Rifampin | 1997 |
A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Erythema; Humans; Interferon Type I; Lepromin; Leprostatic Agents; Leprosy, Lepromatous; Recombinant Proteins; Rifampin | 1997 |
Immunochemotherapy with interferon-gamma and multidrug therapy for multibacillary leprosy.
Topics: Adolescent; Adult; Antibodies, Bacterial; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Interferon-gamma; Leprostatic Agents; Leprosy; Lymphocyte Activation; Male; Middle Aged; Neopterin; Recombinant Proteins; Rifampin; Skin | 1999 |
Effect of zafirlukast on leprosy reactions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Clofazimine; Cohort Studies; Dapsone; Erythema Nodosum; Female; Humans; Indoles; Leprostatic Agents; Leprosy; Leukotriene Antagonists; Male; Middle Aged; Nerve Degeneration; Phenylcarbamates; Prednisone; Rifampin; Sulfonamides; Thalidomide; Tosyl Compounds | 1999 |
Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Oman; Practice Guidelines as Topic; Rifampin; World Health Organization | 1999 |
Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antilepro
Topics: Bacterial Vaccines; Clofazimine; Dapsone; Double-Blind Method; Drug Therapy, Combination; Humans; Immunotherapy; Lepromin; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin; Single-Blind Method; Skin Tests; Vaccines, Inactivated | 1999 |
Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
Topics: Adult; Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Neuritis; Recurrence; Rifampin; World Health Organization | 2000 |
A pilot study of treatment of Buruli ulcer with rifampin and dapsone.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Dapsone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Pilot Projects; Rifampin; Skin Ulcer; Treatment Outcome | 2002 |
Biochemical and hematological side effects of clofazimine in leprosy patients.
Topics: Blood Cell Count; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Rifampin | 2002 |
Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin | 2004 |
Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
Topics: Acedapsone; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; India; Leprostatic Agents; Leprosy, Lepromatous; Male; Microbial Sensitivity Tests; Mycobacterium leprae; Recurrence; Rifampin; World Health Organization | 2004 |
10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; BCG Vaccine; Biological Assay; Clofazimine; Combined Modality Therapy; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Foot; Humans; Immunization, Secondary; Immunotherapy; Leprostatic Agents; Leprosy, Lepromatous; Male; Mice; Middle Aged; Rifampin; Vaccination | 2004 |
International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.
Topics: Adolescent; Adult; Aged; Child; China; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin; Skin Diseases, Bacterial; Treatment Outcome | 2008 |
Plasma levels of chemokines during leprosy specific treatment.
Topics: Adult; Aged; Chemokine CCL11; Chemokine CCL24; Chemokines; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Laboratories; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Treatment Outcome | 2010 |
The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy.
Topics: Adult; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Paucibacillary; Male; Middle Aged; Ofloxacin; Recurrence; Rifampin; Skin; Time Factors; Treatment Outcome; World Health Organization | 2010 |
Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Clofazimine; Dapsone; Drug Therapy, Combination; Eye Diseases; Female; Humans; Infant; Leprostatic Agents; Leprosy, Multibacillary; Longitudinal Studies; Male; Middle Aged; Philippines; Prospective Studies; Rifampin; Young Adult | 2011 |
Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Leprosy, Multibacillary; Leprosy, Tuberculoid; Middle Aged; Prospective Studies; Rifampin; Young Adult | 2012 |
OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
Topics: Adolescent; Adult; Animals; Brazil; Clofazimine; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Mice; Middle Aged; Mycobacterium leprae; Ofloxacin; Prevalence; Rifampin; Secondary Prevention; Skin; Time Factors; Treatment Outcome; World Health Organization; Young Adult | 2012 |
International open trial of uniform multidrug therapy regimen for leprosy patients: Findings & implications for national leprosy programmes.
Topics: Adolescent; Adult; Aged; Child; China; Dapsone; Drug Therapy, Combination; Female; Humans; India; Leprosy; Male; Middle Aged; Rifampin; Treatment Outcome | 2016 |
Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brazil; Child; Child, Preschool; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Leprostatic Agents; Leprosy, Multibacillary; Male; Middle Aged; Recurrence; Rifampin; Time Factors; Treatment Outcome; Young Adult | 2017 |
Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
Topics: Adolescent; Adult; Anemia; Brazil; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Hemoglobins; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin; Risk Factors; Treatment Outcome; Young Adult | 2018 |
421 other study(ies) available for dapsone and rifampin
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Long-spacing collagen in skin biopsies from patients with lepromatous leprosy.
Topics: Animals; Collagen; Connective Tissue; Dapsone; Extracellular Space; Granuloma; Humans; Leprosy; Microscopy, Electron; Mycobacterium leprae; Rifampin; Skin; Staining and Labeling; Streptomycin | 1975 |
Rapid test for drug resistance in leprosy.
Topics: Dapsone; Dihydroxyphenylalanine; Drug Resistance, Microbial; Humans; In Vitro Techniques; Isotope Labeling; Leprosy; Microbial Sensitivity Tests; Mycobacterium leprae; Rifampin; Thymidine | 1977 |
[Leprosy and the nervous system (author's transl)].
Topics: Adult; Antibody Formation; Central Nervous System Diseases; Clofazimine; Dapsone; Diagnosis, Differential; Female; Humans; Leprosy; Male; Motor Neurons; Neurologic Manifestations; Neuromuscular Diseases; Peripheral Nervous System Diseases; Rifampin | 1979 |
The diagnosis and management of dapsone-resistant leprosy.
Topics: Clofazimine; Dapsone; Diagnosis, Differential; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1977 |
Leprosy eradication project of Malta. First published report after 5 years running.
Topics: Adolescent; Adult; Aged; Bacteriological Techniques; Child; Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprosy; Male; Malta; Middle Aged; Prothionamide; Rifampin; Time Factors | 1977 |
A rapid test for bacillary resistance to dapsone.
Topics: Clofazimine; Dapsone; Dihydroxyphenylalanine; Drug Resistance, Microbial; Mycobacterium leprae; Rifampin; Thymidine | 1978 |
In vitro resistance test of human leprosy bacilli to anti-leprous drugs.
Topics: Dapsone; Drug Resistance, Microbial; Humans; Isoniazid; Leprostatic Agents; Leprosy; Microbial Sensitivity Tests; Mycobacterium leprae; Rifampin; Streptomycin | 1977 |
Committee 4: workshop on experimental chemotherapy of leprosy.
Topics: Animals; Antitubercular Agents; Clofazimine; Dapsone; Drug Resistance, Microbial; Leprostatic Agents; Leprosy; Mice; Mycobacterium leprae; Rifampin; Sulfamethoxypyridazine | 1979 |
[Comparative study of the variable averages and bacilloscopic and morphologic indexes in Virchowian Hansen patients treated with rifampicin and diaminediphenylsulfone].
Topics: Dapsone; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1979 |
Dapsone alone compared with dapsone plus rifampicin in short-term therapy of lepromatous leprosy.
Topics: Dapsone; Drug Therapy, Combination; Erythema Nodosum; Female; Humans; Leprosy; Malaysia; Male; Mycobacterium leprae; Rifampin | 1977 |
The treatment of leprosy today and tomorrow: the LEPRA consultation on chemotherapy.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Patient Compliance; Rifampin | 1977 |
[Research in the campaign against leprosy (author's transl)].
Topics: Animals; Armadillos; Dapsone; Drug Therapy, Combination; Humans; Isoniazid; Leprosy; Mice; Models, Biological; Mycobacterium; Prothionamide; Rifampin | 1977 |
Workshop on "chemotherapy of leprosy" at the Central Leprosy Teaching and Research Institute, Chengalpattu (Tamil Nadu) on 21 January 1978.
Topics: Clofazimine; Dapsone; Humans; India; Leprosy; Recurrence; Rifampin; Thalidomide | 1979 |
Influence of rifampicin on D.D.S. excretion in urine.
Topics: Adult; Dapsone; Female; Humans; Leprosy; Male; Rifampin | 1979 |
Lepromatous iridocyclitis diagnosed by anterior chamber paracentesis.
Topics: Adult; Anterior Chamber; Atropine; Biopsy; Dapsone; Humans; Leprosy; Male; Prednisone; Punctures; Rifampin; Sclera; Triamcinolone; Uveitis, Anterior | 1979 |
Combined therapy in leprosy. Background and findings.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Leprostatic Agents; Leprosy; Prothionamide; Rifampin | 1978 |
[In-vitro potentiation of the anti-tuberculous effects of rifampicin and ethionamide by 4,4-diamino-diphenylsulphone (author's transl)].
Topics: Dapsone; Dose-Response Relationship, Drug; Drug Synergism; Ethionamide; In Vitro Techniques; Mycobacterium tuberculosis; Rifampin | 1975 |
[In-vitro study of the effects of 4,4-diamino-diphenylsulphone in combination with isoniazid and rifampicin (author's transl)].
Topics: Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; In Vitro Techniques; Isoniazid; Mycobacterium leprae; Mycobacterium tuberculosis; Rifampin | 1975 |
Leprosy--a social disease.
Topics: Attitude to Health; Bacterial Vaccines; BCG Vaccine; Dapsone; Humans; India; Leprosy; Patient Compliance; Physical Therapy Modalities; Rehabilitation, Vocational; Rifampin; Surgery, Plastic; World Health Organization | 1977 |
The diagnosis and treatment of leprosy.
Topics: Biopsy; Clofazimine; Dapsone; Erythema Nodosum; Humans; Immunotherapy; Leprosy; Recurrence; Rifampin; Sensation; Skin; Thalidomide; United States | 1976 |
Tuberculoid leprosy.
Topics: Adult; Dapsone; Diagnosis, Differential; Female; Humans; Leprosy; Rifampin; Skin Manifestations; Tuberculosis, Cutaneous; United Kingdom | 1976 |
[Treatment of severe open cavitary pulmonary tuberculosis with a combination of rifampicin and isoprodian (author's transl)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Male; Middle Aged; Prothionamide; Rifampin; Tuberculosis, Pulmonary | 1976 |
Treatment of Hansen's disease.
Topics: Chloroquine; Clofazimine; Dapsone; Drug Resistance, Microbial; Erythema Nodosum; Humans; Leprosy; Prednisone; Rifampin; Thalidomide | 1976 |
[New drugs in the treatment of leprosy].
Topics: Dapsone; Drug Combinations; Drug Evaluation; Humans; Isoniazid; Isonicotinic Acids; Leprosy; Prothionamide; Rifampin; Tablets | 1976 |
Dapsone metabolism in patients with dapsone-resistant leprosy.
Topics: Acetylation; Dapsone; Drug Resistance; Female; Humans; Leprosy; Male; Metabolic Clearance Rate; Mycobacterium leprae; Phenotype; Rifampin; Sulfamethazine | 1975 |
Importance of nasal lesions in early lepromatous leprosy.
Topics: Dapsone; Humans; Leprosy; Mycobacterium leprae; Nasal Mucosa; Nose Diseases; Rifampin | 1975 |
Treatment of neuritis in borderline leprosy with rifampicin and corticosteroids--a pilot trial.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Neuritis; Pilot Projects; Prednisone; Rifampin | 1975 |
Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Prothionamide; Rifampin | 1975 |
Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
Topics: Adolescent; Adult; Child; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothionamide; Rifampin | 1975 |
The effect of rifampicin on dapsone metabolism.
Topics: Acetylation; Dapsone; Half-Life; Humans; Leprosy; Protein Binding; Rifampin; Sulfamethazine | 1975 |
The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves.
Topics: Animals; Dapsone; Dogs; Isoniazid; Peripheral Nerves; Pyrazinamide; Rifampin; Sciatic Nerve; Sheep; Time Factors | 1975 |
The drug treatment of leprosy.
Topics: Acute Disease; Adrenal Cortex Hormones; Aniline Compounds; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Rifampin; Thalidomide; Thiourea | 1975 |
Drug interactions in use of dapsone for Pneumocystis carinii prophylaxis.
Topics: Dapsone; Drug Interactions; HIV Infections; Humans; Pneumonia, Pneumocystis; Rifampin | 1992 |
Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Clofazimine; Dapsone; Drug Eruptions; Drug Synergism; Drug Therapy, Combination; Female; Humans; Incidence; Leprosy; Male; Middle Aged; Rifampin; Syndrome; Vanuatu | 1992 |
Leprosy in French Polynesia. The possible impact of multidrug therapy on epidemiological trends.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Humans; Leprosy; Polynesia; Rifampin | 1992 |
Neuritic leprosy: epidemiology and therapeutic responsiveness.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Tuberculoid; Male; Rifampin | 1992 |
Significance of drug interactions with rifampin in Pneumocystis carinii pneumonia prophylaxis.
Topics: Dapsone; Drug Interactions; Humans; Pneumonia, Pneumocystis; Rifampin | 1992 |
Delayed clearance of circulating immune complexes in mice following administration of antileprosy drugs.
Topics: Animals; Antigen-Antibody Complex; Clofazimine; Dapsone; Kinetics; Leprostatic Agents; Male; Mice; Rifampin; Serum Albumin | 1992 |
An experimental study to evaluate the bactericidal activity of ofloxacin against an established Mycobacterium leprae infection.
Topics: Animals; Dapsone; Disease Models, Animal; Drug Therapy, Combination; Leprosy; Mice; Mice, Nude; Mycobacterium leprae; Ofloxacin; Rifampin; Serum Bactericidal Test | 1992 |
Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR.
Topics: Anti-Bacterial Agents; Biopsy; Clofazimine; Dapsone; DNA Probes; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Agar Gel; Feasibility Studies; Humans; Leprosy; Mycobacterium leprae; Nucleic Acid Hybridization; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Skin | 1992 |
Lepromatous leprosy: nasal manifestations and treatment with minocycline.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Lepromatous; Male; Minocycline; Nose Diseases; Rifampin | 1992 |
Eight years of follow-up of paucibacillary patients treated with short-course regimens.
Topics: Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprosy; Recurrence; Rifampin | 1992 |
Tuberculosis and leprosy--not uncommon association.
Topics: Adult; Dapsone; Humans; Leprosy, Tuberculoid; Male; Rifampin; Tuberculosis, Pulmonary | 1992 |
Effect of anti-leprosy drugs on superoxide anion production by rat peritoneal macrophage with special reference to light exposed clofazimine.
Topics: Animals; Clofazimine; Dapsone; In Vitro Techniques; Leprostatic Agents; Light; Macrophages; Mycobacterium leprae; Peritoneal Cavity; Rats; Rifampin; Staphylococcus aureus; Superoxides | 1991 |
[Use of tuftsin in experimental leprosy].
Topics: Animals; Cell Line; Dapsone; Leprosy; Mice; Mice, Inbred CBA; Mycobacterium leprae; Rifampin; Tuftsin | 1991 |
Fatty acid oxidation and the beta-oxidation complex in Mycobacterium leprae and two axenically cultivable mycobacteria that are pathogens.
Topics: Acetyl Coenzyme A; Clofazimine; Dapsone; Fatty Acids; Laurates; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Mycobacterium leprae; Oxidation-Reduction; Rifampin | 1991 |
The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Carbohydrate Sequence; Clofazimine; Dapsone; Drug Therapy, Combination; Glycolipids; Humans; Immunoglobulin M; Leprostatic Agents; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Molecular Sequence Data; Mycobacterium leprae; Rifampin; Skin; Time Factors | 1991 |
In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
Topics: Animals; Armadillos; Benzylamines; Dapsone; Leprostatic Agents; Leprosy; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium leprae; Rifampin | 1991 |
A retrospective study on seven years of multiple drug treatment for paucibacillary and multibacillary leprosy, in Bayara General Hospital, Nigeria.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Health Services Accessibility; Hospitals, General; Humans; Leprostatic Agents; Leprosy; Male; Nigeria; Patient Compliance; Recurrence; Retrospective Studies; Rifampin; Sex Factors | 1991 |
Impact of multidrug therapy on the treatment and control of leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Global Health; Humans; Leprosy; Patient Compliance; Rifampin | 1991 |
Radiolabeling of Mycobacterium leprae lipids within schwannoma cells, a potential drug screening system.
Topics: Acetates; Dapsone; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Isotope Labeling; Kinetics; Leprostatic Agents; Lipid Metabolism; Mycobacterium leprae; Neurilemmoma; Phagocytosis; Rifampin; Tumor Cells, Cultured | 1991 |
Cytogenetic studies in leprosy patients before and after chemotherapy.
Topics: Adult; Aged; Cell Cycle; Cells, Cultured; Chromosome Aberrations; Dapsone; Female; Follow-Up Studies; Humans; Karyotyping; Leprosy; Male; Middle Aged; Mitotic Index; Rifampin; Sister Chromatid Exchange | 1991 |
The activity of amoxicillin plus clavulanic acid against Mycobacterium leprae in mice.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Dapsone; Drug Therapy, Combination; Kanamycin; Kinetics; Leprosy; Mice; Mycobacterium leprae; Rifampin | 1991 |
Fixed duration MDT in paucibacillary leprosy.
Topics: Adolescent; Adult; Aged; Child; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy, Borderline; Leprosy, Tuberculoid; Male; Middle Aged; Rifampin; Time Factors | 1991 |
A case of relapse with drug-susceptible M. leprae after multidrug therapy.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Male; Mycobacterium leprae; Prothionamide; Recurrence; Rifampin; Sulfamethoxypyridazine | 1991 |
Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Middle Aged; Mycobacterium leprae; Rifampin; Time Factors | 1991 |
[Short- and long-term results of tuberculosis therapy with a fixed combination of isoniazide, prothionamide and diaminodiphenylsulfone combined with rifampicin].
Topics: Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Isonicotinic Acids; Long-Term Care; Male; Prothionamide; Rifampin; Tuberculosis, Pulmonary | 1990 |
Effect of simultaneous administration of interferon-gamma and chemotherapy against Mycobacterium leprae in experimental infection in nude mice.
Topics: Animals; Combined Modality Therapy; Dapsone; Drug Therapy, Combination; Interferon-gamma; Leprosy; Mice; Mice, Nude; Recombinant Proteins; Rifampin | 1990 |
Uptake of purine and pyrimidine nucleosides by macrophage-resident Mycobacterium leprae: 3H-adenosine as an indicator of viability and antimicrobial activity.
Topics: Animals; Armadillos; Cells, Cultured; Dapsone; Humans; Kinetics; Macrophages; Mice; Mycobacterium leprae; Purine Nucleosides; Pyrimidine Nucleosides; Rifampin | 1990 |
[Late reversal reactions in leprosy].
Topics: Clofazimine; Dapsone; Drug Combinations; Ethionamide; Female; Humans; Leprosy; Male; Recurrence; Rifampin | 1990 |
Histological changes in tuberculoid leprosy after fixed duration multidrug therapy for six months.
Topics: Dapsone; Drug Combinations; Epithelium; Granuloma; Humans; Leprosy, Tuberculoid; Lymphocytes; Prospective Studies; Rifampin; Skin; Time Factors | 1990 |
The chemotherapy of leprosy. Part 1.
Topics: Animals; Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Ethionamide; Humans; Leprosy; Mycobacterium leprae; Prothionamide; Rifampin | 1990 |
[Drugs used in tuberculosis and leprosy].
Topics: Administration, Oral; Antibiotics, Antitubercular; Clofazimine; Dapsone; Humans; Injections, Intramuscular; Isoniazid; Leprostatic Agents; Leprosy; Rifampin; Streptomycin; Tuberculosis | 1990 |
Simultaneous occurrence of upgrading and downgrading type 1 (lepra) reaction.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Male; Rifampin; Time Factors | 1990 |
Effect of three-year multidrug therapy in multibacillary leprosy patients.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Male; Middle Aged; Rifampin | 1990 |
Susceptibilities of Mycobacterium leprae and M. avium complex to the H2O2-Fe-mediated halogenation system supplemented with antimicrobial agents.
Topics: Animals; Clofazimine; Dapsone; Ethidium; Ferrous Compounds; Fluoresceins; Humans; Hydrogen Peroxide; Iodides; Mice; Mycobacterium avium Complex; Mycobacterium leprae; Ofloxacin; Rifampin; Sodium Iodide; Staining and Labeling | 1989 |
Multiple cold abscesses in a borderline lepromatous patient on multidrug therapy.
Topics: Abscess; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Ethambutol; Hip Joint; Humans; Isoniazid; Leprosy, Borderline; Leprosy, Lepromatous; Male; Rifampin; Tuberculosis, Osteoarticular | 1989 |
Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Mice; Middle Aged; Mycobacterium leprae; Rifampin | 1989 |
Study of multidrug therapy in paucibacillary leprosy.
Topics: Administration, Oral; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1989 |
Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Mycobacterium leprae; Paraguay; Patient Compliance; Prothionamide; Rifampin; Time Factors | 1989 |
Antagonism between dapsone and rifampicin in experimental Mycobacterium leprae infections in mice.
Topics: Animals; Dapsone; Drug Interactions; Drug Therapy, Combination; Female; Leprosy; Mice; Mycobacterium leprae; Rifampin | 1989 |
Bacillaemia in leprosy and effect of multidrug therapy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Male; Middle Aged; Mycobacterium leprae; Rifampin; Sepsis; Skin | 1989 |
Vitiligo following type II lepra reaction.
Topics: Autoimmune Diseases; Clofazimine; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprosy, Lepromatous; Male; Middle Aged; Rifampin; Vitiligo | 1989 |
Importance of rifampicin in combined daily/intermittent chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Prothionamide; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 1989 |
Impact of multidrug therapy on leprosy in Baroda district (Gujarat).
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; India; Leprosy; National Health Programs; Patient Compliance; Rifampin | 1989 |
Evaluation of two multidrug regimen in hospitalised multibacillary cases.
Topics: Clofazimine; Dapsone; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Hospitalization; Humans; Leprosy; Rifampin | 1989 |
Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.
Topics: Adult; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lepromin; Leprosy; Male; Recurrence; Rifampin | 1989 |
Leprosy in infants--report of two cases.
Topics: Dapsone; Female; Humans; Infant; Leprosy; Rifampin | 1989 |
Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
Topics: Animals; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isonicotinic Acids; Leprosy; Mice; Prothionamide; Rifampin | 1989 |
Drug resistance and multi-drug therapy in leprosy.
Topics: Animals; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Mice; Rifampin | 1989 |
Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
Topics: Adult; China; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Male; Middle Aged; Retrospective Studies; Rifampin; Skin | 1989 |
Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
Topics: Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; India; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Recurrence; Rifampin | 1989 |
A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
Topics: Adolescent; Adult; Antibodies, Bacterial; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Ethionamide; Fluorescent Antibody Technique; Humans; Leprosy; Middle Aged; Mycobacterium leprae; New Caledonia; Rifampin; T-Lymphocytes; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1986 |
Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient.
Topics: Adult; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprosy, Tuberculoid; Male; Mycobacterium leprae; Rifampin | 1988 |
[Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
Topics: Adolescent; Adult; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Middle Aged; Rifampin | 1987 |
The first joint THELEP-Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy.
Topics: Dapsone; Drug Resistance, Microbial; Humans; Isoniazid; Leprosy; Mycobacterium leprae; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1987 |
Lactate dehydrogenase isoenzymes in leprosy patients on multi drug therapy--a preliminary report.
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoenzymes; L-Lactate Dehydrogenase; Leprosy; Rifampin | 1988 |
Relapse of paucibacillary leprosy after short course multidrug therapy.
Topics: Adult; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leprosy, Tuberculoid; Male; Middle Aged; Recurrence; Rifampin | 1988 |
A clinico-pathological study of multidrug regimen in paucibacillary leprosy.
Topics: Adolescent; Adult; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Middle Aged; Remission Induction; Rifampin | 1988 |
Leprosy control based on multi drug treatment in India.
Topics: Allied Health Personnel; Clofazimine; Dapsone; Data Collection; Drug Administration Schedule; Drug Therapy, Combination; Humans; India; Leprosy; National Health Programs; Patient Compliance; Recurrence; Rifampin | 1988 |
Rifampicin induced uterine bleeding.
Topics: Adult; Dapsone; Drug Therapy, Combination; Endometrium; Female; Humans; Leprosy, Tuberculoid; Rifampin; Uterine Hemorrhage | 1988 |
Occurrence of reversal reactions in BT patients during who paucibacillary leprosy MDT (1982).
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Leprosy, Borderline; Male; Rifampin | 1988 |
Clofazimine and dapsone compliance in leprosy.
Topics: Clofazimine; Dapsone; Humans; Leprosy, Lepromatous; Patient Compliance; Pilot Projects; Rifampin; Self Administration | 1988 |
Primary hyperpigmented cutaneous lesions in tuberculoid leprosy.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Leprosy, Tuberculoid; Male; Pigmentation Disorders; Rifampin | 1988 |
Multidrug therapy in hospitalised leprosy cases.
Topics: Adult; Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Rifampin | 1988 |
[Guinea: detection of leprosy and treatment by polychemotherapy].
Topics: Africa, Western; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Rifampin | 1988 |
On multi-drug combinations in the treatment of leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Humans; Leprosy; Rifampin | 1988 |
Effect of multidrug therapy on the levels of antibodies to Mycobacterium leprae glycolipid-1 in the leprosy spectrum.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Clofazimine; Dapsone; Drug Therapy, Combination; Glycolipids; Humans; Leprosy, Lepromatous; Radioimmunoassay; Rifampin | 1988 |
Paucibacillary leprosy: a comparative study of different schedules of multidrug therapy.
Topics: Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Male; Rifampin | 1988 |
Pattern of relapses in pauci-bacillary leprosy patients treated with M.D.T. (W.H.O. 1982).
Topics: Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Recurrence; Rifampin; Sex Factors | 1988 |
Multidrug therapy in paucibacillary leprosy--a five year experience.
Topics: Adolescent; Adult; Child; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Prospective Studies; Rifampin | 1988 |
Concepts behind the development of multiple drug therapy regimens in leprosy.
Topics: Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin | 1986 |
Detection of persisting Mycobacterium leprae by inoculation of the neonatally thymectomized rat.
Topics: Animals; Animals, Newborn; Dapsone; Humans; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Rats; Rifampin; Thymectomy | 1987 |
Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria.
Topics: Adolescent; Adult; Aged; Clofazimine; Dapsone; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; Humans; Leprosy; Male; Middle Aged; Nigeria; Patient Compliance; Rifampin | 1988 |
Diagnosis of leprosy.
Topics: Clofazimine; Dapsone; Diagnosis, Differential; Drug Combinations; Humans; Leprosy; Rifampin | 1988 |
Drug interaction during multidrug regimens for treatment of leprosy.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Leprosy; Rifampin | 1988 |
A borderline leprosy lesion on the palate: a case report.
Topics: Dapsone; Female; Humans; Leprosy; Middle Aged; Mouth Mucosa; Palate; Prednisolone; Rifampin | 1988 |
Preliminary appraisal of a WHO-recommended multiple drug regimen in paucibacillary leprosy patients in Malawi.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Dapsone; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Leprosy; Malawi; Male; Middle Aged; Patient Compliance; Rifampin; Sex Factors | 1988 |
Treatment of paucibacillary leprosy by WHO regimen.
Topics: Adolescent; Adult; Child; Dapsone; Drug Combinations; Female; Humans; Leprosy; Male; Middle Aged; Rifampin; World Health Organization | 1987 |
Paucibacillary leprosy and W.H.O. regimen.
Topics: Adrenal Cortex Hormones; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Tuberculoid; Rifampin; World Health Organization | 1987 |
New multidrug regimen with indigenous drugs and dapsone in the treatment of lepromatous leprosy (preliminary report).
Topics: Animals; Anti-Infective Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Fatty Acids; Humans; Leprosy, Lepromatous; Mice; Plant Oils; Rifampin; Triterpenes | 1987 |
[Sulfone-resistance of Mycobacterium leprae--monotherapy with diaminodiphenylsulfone--the value of triple-drug combinations].
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1986 |
Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Glycolipids; Humans; Immunoglobulin G; Immunoglobulin M; Leprostatic Agents; Leprosy; Longitudinal Studies; Mycobacterium leprae; Rifampin; Time Factors | 1986 |
The killing of Mycobacterium leprae in mice by various dietary concentrations of dapsone and rifampicin.
Topics: Animals; Dapsone; Dose-Response Relationship, Drug; Mice; Mycobacterium leprae; Rifampin | 1986 |
[Therapy of leprosy today].
Topics: Clofazimine; Dapsone; Drug Resistance; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 1987 |
Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients.
Topics: Adult; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprosy; Male; Middle Aged; Rifampin; Time Factors | 1987 |
Preliminary evaluation of the effect of WHO-MDT on disabilities in leprosy patients in Malaŵi (Central Africa).
Topics: Dapsone; Drug Therapy, Combination; Humans; Leprosy; Malawi; Rifampin | 1986 |
Combined chemotherapy of multibacillary leprosy of 6 months' duration.
Topics: Adolescent; Adult; Child; Child, Preschool; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothionamide; Recurrence; Rifampin | 1986 |
The future of leprosy in the Dominican Republic: experience with multidrug therapy.
Topics: Adolescent; Child; Child, Preschool; Clofazimine; Dapsone; Dominican Republic; Drug Therapy, Combination; Female; Humans; Infant; Leprostatic Agents; Leprosy; Male; Rifampin | 1986 |
Preliminary results of treatment of leprosy patients in The Netherlands with daily rifampicin, dapsone and clofazimine.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Netherlands; Recurrence; Rifampin | 1986 |
The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothionamide; Rifampin | 1986 |
First assessment of the Malta Leprosy Eradication Project.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Malta; Prothionamide; Recurrence; Rifampin | 1986 |
Report of the joint leprosy-tuberculosis project in Paraguay.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Leprostatic Agents; Leprosy; Paraguay; Prothionamide; Rifampin; Tuberculosis | 1986 |
The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Prothionamide; Rifampin; Tanzania | 1986 |
Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Kinetics; Leprosy; Male; Middle Aged; Rifampin | 1986 |
Feasibility of multidrug therapy (MDT) in Hansen's disease in an urban population--Curupaiti State Hospital, Rio de Janeiro, Brazil.
Topics: Adolescent; Adult; Brazil; Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Female; Humans; Leprostatic Agents; Leprosy; Male; Patient Acceptance of Health Care; Patient Compliance; Prednisolone; Prothionamide; Rifampin; Urban Population | 1987 |
Short-course multidrug therapy for leprosy patients in western Kenya. Preliminary communication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Middle Aged; Pilot Projects; Prospective Studies; Rifampin | 1987 |
Effective prophylactic measures against accidental inoculation with live Mycobacterium leprae in laboratory and hospital workers.
Topics: Accidents, Occupational; Dapsone; Humans; Laboratories; Leprosy; Personnel, Hospital; Punctures; Rifampin | 1987 |
Multidrug therapy for paucibacillary leprosy: WHO regimen inadequate?
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Rifampin; World Health Organization | 1987 |
A study of drug interactions in leprosy--1. Effect of simultaneous administration of prothionamide on metabolic disposition of rifampicin and dapsone.
Topics: Dapsone; Drug Interactions; Humans; Isonicotinic Acids; Kinetics; Leprosy; Prothionamide; Rifampin | 1986 |
Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Topics: Adult; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Edema; Erythema Nodosum; Ethionamide; Female; Humans; Leprostatic Agents; Leprosy; Male; Neuritis; Prospective Studies; Rifampin | 1986 |
Electrogustometry in Hansen's disease (study of 225 cases).
Topics: Adolescent; Adult; Ageusia; Clofazimine; Dapsone; Erythema Nodosum; Facial Paralysis; Female; Humans; Leprosy; Male; Rifampin; Taste Disorders | 1986 |
Acute renal failure--a complication of new multidrug regimen for treatment of leprosy.
Topics: Acute Kidney Injury; Adult; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Humans; Leprosy; Male; Nephritis, Interstitial; Rifampin | 1986 |
Implementation of multidrug therapy in the ALERT Leprosy Programme in the Shoa Region of Ethiopia. First results with paucibacillary patients.
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Ethiopia; Humans; Leprosy; Rifampin | 1986 |
Monitoring dapsone self-administration in a multidrug therapy programme.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Ethiopia; Female; Humans; Leprosy; Male; Middle Aged; Patient Compliance; Rifampin; Self Administration | 1986 |
[Combination chemotherapy in leprosy].
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 1986 |
The effect of clofazimine on the pharmacokinetics of rifampicin and dapsone in leprosy.
Topics: Clofazimine; Dapsone; Half-Life; Humans; Kinetics; Leprosy; Rifampin | 1986 |
Radio diagnosis of skin disease.
Topics: Adult; Dapsone; Female; Humans; Leprosy; Patient Education as Topic; Physician-Patient Relations; Radio; Rifampin | 1987 |
Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro.
Topics: Clofazimine; Dapsone; Dinoprostone; Female; Humans; In Vitro Techniques; Kinetics; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Prostaglandins E; Rifampin | 1985 |
Leprosy and the eye: a review.
Topics: Bacterial Vaccines; Clofazimine; Dapsone; Drug Therapy, Combination; Eye Diseases; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1985 |
Detection of phenolic glycolipid I in sera from patients with lepromatous leprosy.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Dapsone; Glycolipids; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1985 |
Recent trends in chemotherapy of leprosy.
Topics: Clofazimine; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Leprostatic Agents; Leprosy; Mycobacterium leprae; Prothionamide; Rifampin | 1985 |
Absence from sera from normal individuals or from rifampin-treated leprosy patients (THELEP trials) of antibody to rifamycin-protein or rifamycin-membrane conjugates.
Topics: Animals; Antibodies, Bacterial; Clofazimine; Coombs Test; Dapsone; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Erythrocyte Membrane; Humans; Immunoglobulin G; Immunoglobulin M; Leprosy; Lymphocytes; Mice; Rifampin; Rifamycins; Serum Albumin | 1985 |
Polytherapy in multibacillary leprosy patients in Nepal.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Prothionamide; Rifampin; Sex Ratio; Time Factors | 1985 |
Negative observations on immunological side effects of rifampin and dapsone in mice.
Topics: Animals; Antibody Formation; Dapsone; Female; Hypersensitivity, Delayed; Immunity; Immunity, Cellular; Leprostatic Agents; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phagocytosis; Rifampin; Viral Plaque Assay | 1985 |
Effect of rifampicin on the biological activity of tubulin.
Topics: Animals; Brain Chemistry; Cattle; Chromatography, Gel; Colchicine; Dapsone; Guanosine Triphosphate; Kinetics; Macromolecular Substances; Microtubules; Phenobarbital; Rifampin; Spectrophotometry; Tubulin | 1985 |
Failure of a prothionamide-containing oral antituberculosis regimen.
Topics: Administration, Oral; Antitubercular Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Male; Patient Compliance; Prothionamide; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1985 |
Antileprosy drugs.
Topics: Anemia, Hemolytic; Aniline Compounds; Anti-Bacterial Agents; Dapsone; Drug Resistance, Microbial; Humans; Injections, Intramuscular; Leprosy; Mycobacterium leprae; Phenazines; Rifampin; Sulfonamides; Sulfones; Thioacetazone; Thiourea | 1971 |
Kinetic testing of drugs against Mycobacterium leprae in mice. Activity of cephaloridine, rifampin, streptovaricin, vadrine, and viomycin.
Topics: Animals; Antimalarials; Cephaloridine; Dapsone; Diet; Evaluation Studies as Topic; Injections, Subcutaneous; Kinetics; Leprosy; Malaria; Methods; Mice; Mycobacterium leprae; Oxadiazoles; Pyridines; Rifampin; Salicylates; Streptovaricin; Viomycin | 1971 |
Editorial: Problems and opportunities in the therapy of leprosy.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Rifampin | 1974 |
The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
Topics: Administration, Oral; Animal Feed; Animals; Dapsone; Drug Resistance, Microbial; Kinetics; Leprosy; Mice; Microbial Sensitivity Tests; Mycobacterium leprae; Rifampin; Time Factors | 1972 |
The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS).
Topics: Animals; Biopsy; Dapsone; Humans; Leprosy; Mice; Mycobacterium leprae; Rifampin; Skin | 1972 |
Rapid bactericidal effect of rifampin on Mycobacterium leprae.
Topics: Animals; Biopsy; Dapsone; Humans; Leprosy; Mice; Mycobacterium leprae; Rifampin; Skin | 1972 |
Correlation of laboratory and clinical data during treatment of leprosy.
Topics: Aniline Compounds; Animals; Antimalarials; Dapsone; Drug Resistance, Microbial; Humans; Imines; Leprosy; Male; Mice; Mycobacterium leprae; Phenazines; Pigmentation Disorders; Rifampin; Sulfonamides | 1972 |
The effect of antibacterial drugs on the ultrastructure of Mycobacterium leprae in human skin.
Topics: Anti-Bacterial Agents; Dapsone; Humans; Leprosy; Microscopy, Electron; Mycobacterium leprae; Rifampin; Skin; Streptomycin | 1972 |
Behavior of Mycobacterium leprae in human macrophages in vitro.
Topics: Bacteriological Techniques; Cell Division; Dapsone; Hot Temperature; Humans; Macrophages; Mycobacterium leprae; Rifampin | 1973 |
Ulcerating lepromatous leprosy in a patient with dapsone-resistant Mycobacterium leprae.
Topics: Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Skin Ulcer | 1973 |
Fundamental data, methods and goals of present research on the treatment of leprosy.
Topics: Animals; Animals, Laboratory; Antitubercular Agents; Clofazimine; Dapsone; Ethionamide; Humans; In Vitro Techniques; Isoniazid; Leprosy; Mice; Mycobacterium lepraemurium; Rifampin; Sulfonamides; Trimethoprim | 1973 |
[Initial clinical results using new, experimentally developed therapeutic forms in leprosy].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Dapsone; Drug Therapy, Combination; Ethiopia; Female; Histocytochemistry; Humans; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Skin; Sulfonamides; Thalidomide; Time Factors; Trimethoprim | 1973 |
Dapsone resistance in leprosy.
Topics: Animals; Clofazimine; Dapsone; Drug Resistance, Microbial; Leprosy; Mice; Mycobacterium leprae; Rifampin | 1973 |
The effect of rifampicin on Mycobacterium leprae in mice.
Topics: Animals; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Mice; Mycobacterium leprae; Rifampin; Time Factors | 1974 |
Viability of blood-borne Mycobacterium leprae.
Topics: Adult; Aged; Animals; Dapsone; Female; Humans; Leprosy; Male; Mice; Middle Aged; Mycobacterium leprae; Rifampin; Sepsis; Skin | 1974 |
A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
Topics: Aniline Compounds; Animals; Dapsone; Disease Models, Animal; Drug Combinations; Ethionamide; Humans; Isoniazid; Leprosy; Mice; Models, Biological; Mycobacterium Infections; Phenazines; Pyrazines; Rabbits; Rifampin; Sulfonamides; Trimethoprim | 1972 |
Drugs for leprosy.
Topics: Adult; Animals; Biopharmaceutics; Dapsone; Humans; Leprosy; Mice; Phenazines; Rifampin; Thiourea | 1973 |
Lepromatous leprosy.
Topics: Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Male; Middle Aged; Rifampin | 1973 |
[Administration of a new antimycobacterial combined therapy in leprosy in East Africa].
Topics: Africa, Eastern; Antitubercular Agents; Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprosy; Male; Prognosis; Pyrazines; Rifampin; Sulfanilamides; Time Factors | 1973 |
Clinical correlates of C1Q-precipitating substances in the sera of patients with leprosy.
Topics: Complement System Proteins; Cryoglobulins; Dapsone; Humans; Leprosy; Precipitin Tests; Precipitins; Prednisone; Rifampin | 1974 |
Transmission of human leprosy to the mouse and its clinical implications.
Topics: Animals; Communicable Diseases; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Hindlimb; Humans; Leprosy; Mice; Microscopy, Electron; Muscles; Mycobacterium leprae; Rifampin; Sciatic Nerve | 1970 |
Systemic chemotherapy in mice experimentally infected with Mycobacterium marinum.
Topics: Administration, Oral; Animals; Dapsone; Demeclocycline; Ethionamide; Female; Isoniazid; Mice; Mice, Inbred Strains; Mycobacterium Infections; Phenylthiourea; Pyrazines; Rifampin; Sulfonamides | 1971 |
Combined treatment for lepromatous leprosy.
Topics: Acedapsone; Animals; Dapsone; Drug Therapy, Combination; Ethionamide; Humans; Leprostatic Agents; Leprosy; Mice; Prothionamide; Rifampin; Thioacetazone | 1980 |
Evaluation of multiple regimens in leprosy.
Topics: Clofazimine; Dapsone; Drug Evaluation; Drug Therapy, Combination; Humans; Leprosy; Male; Rifampin; Sepsis; Thioacetazone | 1981 |
Multiple drug therapy--a comparative study with 2 tier and 3 tier combination of rifampicin, clofazimine, DDS, INAH and thiacetazone in lepromatous cases.
Topics: Adolescent; Adult; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprosy; Male; Middle Aged; Rifampin; Thioacetazone | 1981 |
Evaluation of drug regimen in lepromatous leprosy--II.
Topics: Adult; Animals; Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; Humans; Isoniazid; Leprostatic Agents; Leprosy; Male; Mice; Middle Aged; Rifampin; Thioacetazone | 1983 |
Side-effects of antileprosy drugs in common use.
Topics: Clofazimine; Dapsone; Drug Hypersensitivity; Ethionamide; Humans; Leprostatic Agents; Leprosy; Rifampin; Thioacetazone | 1983 |
Intra-neural ceroid-like pigment following the treatment of lepromatous leprosy with clofazimine (B663; Lamprene).
Topics: Adult; Ceroid; Clofazimine; Dapsone; Drug Therapy, Combination; Histocytochemistry; Humans; Leprosy; Macrophages; Male; Peripheral Nerves; Peripheral Nervous System Diseases; Pigmentation Disorders; Pigments, Biological; Rifampin | 1981 |
The treatment of leprosy.
Topics: Adult; Animals; Clofazimine; Dapsone; Drug Resistance, Microbial; Erythema Nodosum; Ethionamide; Humans; Leprosy; Mycobacterium leprae; Patient Compliance; Prothionamide; Rifampin | 1983 |
How much non-infectious are the "non-infectious" lepromatous leprosy patients?
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium leprae; Nose; Rifampin | 1983 |
Leprosy today.
Topics: Clofazimine; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Rifampin; Syndrome; T-Lymphocytes | 1983 |
Lepromatous leprosy of the larynx.
Topics: Aged; Dapsone; Humans; Laryngeal Diseases; Leprosy; Male; Rifampin | 1983 |
Influence of agents with immunomodulating activity on phagocytosis and bactericidal function of human polymorphonuclear cells.
Topics: Adjuvants, Immunologic; Benzothiazoles; Blood Bactericidal Activity; Clofazimine; Cromolyn Sodium; Dapsone; Humans; Immunosuppressive Agents; Levamisole; Neutrophils; Phagocytosis; Phenylurea Compounds; Rifampin | 1983 |
Successful plasma exchange in type 1 leprosy reversal reaction.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Leukocyte Count; Male; Plasma Exchange; Rifampin; T-Lymphocytes | 1984 |
Late reversal reaction after combined treatment of a patient with multibacillary leprosy.
Topics: Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothionamide; Recurrence; Rifampin | 1984 |
Treatment of leprosy in rural India as seen on a medical student elective.
Topics: Clofazimine; Dapsone; Developing Countries; Drug Therapy, Combination; Humans; India; Leprosy; Patient Compliance; Rifampin; Rural Population | 1984 |
Sural nerve biopsy in leprosy patients after varying periods of treatment: histopathological and bacteriological findings on light microscopy.
Topics: Adolescent; Adult; Biopsy; Child; Dapsone; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prednisolone; Rifampin; Skin; Spinal Nerves; Sural Nerve | 1984 |
Comparative study of two regimens of combined chemotherapy of one year duration in multibacillary leprosy. Results after four and five years' follow-up.
Topics: Adolescent; Adult; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isonicotinic Acids; Leprosy; Male; Middle Aged; Prothionamide; Rifampin | 1984 |
New approaches to chemotherapy for leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 1983 |
Field application of combined therapy for infectious leprosy cases. A feasibility study in Bombay.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Evaluation; Drug Therapy, Combination; Humans; India; Leprosy; Middle Aged; Patient Compliance; Rifampin | 1983 |
Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide.
Topics: Adolescent; Adult; Aging; Amides; Chemical and Drug Induced Liver Injury; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Middle Aged; Rifampin; Sex Factors; Thioamides | 1983 |
Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
Topics: Clofazimine; Dapsone; Drug Packaging; Ethionamide; Humans; Leprostatic Agents; Leprosy; Prothionamide; Rifampin; Tablets | 1983 |
Short-course multi-drug therapy for paucibacillary patients in Guyana: preliminary communication.
Topics: Dapsone; Drug Therapy, Combination; Humans; Leprosy; Rifampin | 1984 |
Leprosy and its chemotherapy.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1982 |
The six disease of WHO.
Topics: Adult; Animals; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Rifampin; Time Factors | 1981 |
Chemotherapy of leprosy for control programmes: scientific basis and practical application.
Topics: Clofazimine; Costs and Cost Analysis; Dapsone; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Prothionamide; Rifampin | 1983 |
Leprosy in Auckland.
Topics: Adult; Clofazimine; Dapsone; Female; Fiji; Humans; Independent State of Samoa; Leprosy; Male; New Zealand; Patient Compliance; Rifampin | 1980 |
Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
Topics: Animals; Dapsone; Drug Therapy, Combination; Female; Leprosy; Male; Mice; Mice, Inbred BALB C; Models, Biological; Mycobacterium leprae; Pregnancy; Rats; Rats, Inbred Strains; Rifampin; Thymectomy | 1980 |
Thymus-dependent lymphocytes in leprosy. II. Effect of chemotherapy on T-lymphocyte subpopulations.
Topics: Antibodies, Monoclonal; Dapsone; Erythema Nodosum; Humans; Leprosy; Lymphocyte Activation; Mycobacterium leprae; Rifampin; T-Lymphocytes; Thalidomide | 1982 |
Follow-up on short-course 2 months' rifampicin treatment of paucibacillary leprosy.
Topics: Dapsone; Follow-Up Studies; Humans; Leprosy; Rifampin | 1982 |
Skin of leprosy patients before and after treatment: electron microscopic study.
Topics: Dapsone; Humans; Leprosy; Macrophages; Microscopy, Electron; Rifampin; Skin | 1982 |
Some thoughts on the present status and future prospects of chemotherapy of leprosy based on experience with treating tuberculosis.
Topics: Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprosy; Rifampin; Tuberculosis | 1981 |
Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Middle Aged; Rifampin | 1981 |
Effect of single dose (1500 mg) rifampicin on infectivity of patients with lepromatous leprosy.
Topics: Animals; Dapsone; Follow-Up Studies; Humans; Leprosy; Mice; Rifampin | 1980 |
Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
Topics: Clofazimine; Creatinine; Dapsone; Drug Interactions; Humans; Leprosy; Rifampin | 1981 |
Changes in neutrophil motility accompanying dapsone and rifampicin therapy.
Topics: Cell Movement; Dapsone; Humans; In Vitro Techniques; Neutrophils; Rifampin; Time Factors | 1981 |
Determination of three main antileprosy drugs and their main metabolites in serum by high-performance liquid chromatography.
Topics: Animals; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Clofazimine; Dapsone; Guinea Pigs; Humans; Leprostatic Agents; Reference Values; Rifampin | 1981 |
Persister M. leprae after introductory rifampicin followed by dapsone therapy.
Topics: Animals; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprosy; Mice; Rifampin | 1981 |
Study on drug interactions.
Topics: Adult; Clofazimine; Dapsone; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Leprosy; Male; Middle Aged; Rifampin | 1980 |
[Reconsidering the treatment of leprosy].
Topics: Animals; Dapsone; Drug Resistance; Humans; Leprosy; Mice; Rifampin | 1980 |
Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
Topics: Adult; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Mycobacterium leprae; Recurrence; Rifampin | 1995 |
[Long-term effect of leprosy control in both highly endemic prefectures, Weifang of Shandong and Wenshan of Yunnan].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; China; Dapsone; Drug Therapy, Combination; Female; Humans; Incidence; Leprostatic Agents; Leprosy; Male; Middle Aged; Prevalence; Rifampin | 1995 |
Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice.
Topics: Animals; Anti-Infective Agents; Clarithromycin; Dapsone; Drug Therapy, Combination; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Minocycline; Quinolones; Rifampin | 1995 |
Response of leprosy patients with single lesions to MDT.
Topics: Adolescent; Adult; Arm; Dapsone; Drug Therapy, Combination; Facial Dermatoses; Follow-Up Studies; Humans; Leg Dermatoses; Leprosy, Borderline; Leprosy, Tuberculoid; Middle Aged; Recurrence; Remission Induction; Rifampin | 1995 |
Leprosy.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Rifampin | 1995 |
[Effects of diaminodiphenylsulfone and rifampicin on biorhythms of lymphocyte level in intact mice].
Topics: Animals; Circadian Rhythm; Dapsone; Lymphocyte Count; Lymphocytes; Mice; Mice, Inbred CBA; Rifampin | 1995 |
A fatal case of drug-induced multi-organ damage in a patient with Hansen's disease: dapsone syndrome or rifampicin toxicity?
Topics: Acute Kidney Injury; Aged; Chemical and Drug Induced Liver Injury; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Fatal Outcome; Humans; Kidney; Leprosy; Liver; Male; Myocarditis; Myocardium; Nephritis, Interstitial; Rifampin | 1995 |
A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
Topics: Adolescent; Adult; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy, Borderline; Leprosy, Tuberculoid; Male; Middle Aged; Prospective Studies; Rifampin; Treatment Outcome | 1994 |
Midborderline (BB)-borderline lepromatous (BL) leprosy with reversal reaction (RR).
Topics: Aged; Biopsy; Clofazimine; Cyclosporine; Dapsone; Diabetes Complications; Humans; Leprosy, Lepromatous; Male; Neurologic Examination; Prednisone; Rifampin | 1994 |
Treating Hansen's disease in developing countries.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Rifampin | 1994 |
Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.
Topics: Adult; Aged; Confidence Intervals; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Male; Middle Aged; Recurrence; Rifampin; Risk Factors; Skin | 1994 |
Rate of relapse in multibacillary patients after cessation of long-course dapsone monotherapy supplemented by a final supervised single dose of 1500 mg of rifampin.
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprosy; Male; Recurrence; Rifampin; Risk Factors; Senegal; Skin | 1994 |
Does drug interaction cause failure of PCP prophylaxis with dapsone?
Topics: Dapsone; Didanosine; Drug Interactions; HIV Infections; Humans; Pneumonia, Pneumocystis; Retrospective Studies; Rifampin | 1993 |
Loss of viability of Mycobacterium leprae isolated from nasal secretions of lepromatous leprosy patients following daily rifampicin and DDS therapy.
Topics: Animals; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Lepromatous; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Nasal Mucosa; Rifampin | 1993 |
Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Electrophysiology; Female; Humans; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Middle Aged; Neural Conduction; Peripheral Nerves; Reaction Time; Rifampin | 1993 |
A simple and rapid technique for the detection of rifampin resistance in Mycobacterium leprae.
Topics: Alleles; Amino Acid Sequence; Base Sequence; Dapsone; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; DNA, Single-Stranded; Drug Resistance, Microbial; Drug Therapy, Combination; Genes, Bacterial; Humans; Leprosy, Lepromatous; Male; Molecular Sequence Data; Mutation; Mycobacterium leprae; Polymerase Chain Reaction; Polymorphism, Genetic; Prothionamide; Recurrence; Rifampin | 1993 |
Pedal edema following clofazimine therapy; a case report.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Edema; Foot Diseases; Humans; Leprosy, Borderline; Male; Middle Aged; Rifampin; Toes | 1993 |
[Apropos of a case of perforating, leprous plantar ulcer occuring at 15 years of age].
Topics: Adolescent; Anti-Bacterial Agents; Bone Diseases; Dapsone; Drug Therapy, Combination; Female; Foot; Foot Deformities, Acquired; Foot Ulcer; Hand Deformities, Acquired; Humans; Hypesthesia; Leprosy, Tuberculoid; Rifampin | 1994 |
Emergence of leprosy in a patient with mycosis fungoides.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dapsone; Humans; Leprosy, Lepromatous; Male; Middle Aged; Mycosis Fungoides; Photopheresis; Rifampin; Skin Diseases, Bacterial; Skin Neoplasms | 1994 |
Therapeutic monitoring and pharmacist intervention in a Hansen's disease clinic.
Topics: Academic Medical Centers; Chicago; Clofazimine; Dapsone; Drug Monitoring; Humans; Leprosy; Patient Care Team; Patient Compliance; Pharmacy Service, Hospital; Rifampin | 1993 |
Problems of leprosy relapse in China.
Topics: China; Clofazimine; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprosy; Recurrence; Retrospective Studies; Rifampin; Risk Factors | 1993 |
Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Clofazimine; Dapsone; Drug Therapy, Combination; Glycolipids; Humans; Immunoglobulin G; Immunoglobulin M; Isoelectric Focusing; Leprostatic Agents; Leprosy, Lepromatous; Mycobacterium bovis; Mycobacterium leprae; Patient Compliance; Prothionamide; Rifampin | 1993 |
Serological monitoring of the response to chemotherapy in leprosy patients.
Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Antigens, Bacterial; Child; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Glycolipids; Humans; Immunoglobulin G; Immunoglobulin M; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Lipopolysaccharides; Male; Middle Aged; Mycobacterium leprae; Rifampin | 1993 |
Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Topics: Administration, Oral; Animals; Clarithromycin; Dapsone; Drug Interactions; Drug Resistance, Microbial; Female; Leprosy; Mice; Mycobacterium leprae; Rifampin | 1993 |
Survey for secondary dapsone and rifampicin resistance in Cuba.
Topics: Animals; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprosy; Male; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Rifampin | 1993 |
Efficacy and safety of multidrug therapy in paucibacillary leprosy in Singapore.
Topics: Adult; Aged; Aged, 80 and over; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin | 1993 |
Urinary excretion of renal brush border membrane enzymes in leprosy patients--effect of multidrug therapy.
Topics: Alkaline Phosphatase; Biomarkers; Clofazimine; Dapsone; Drug Monitoring; Drug Therapy, Combination; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Kidney; Leprostatic Agents; Leprosy; Leucyl Aminopeptidase; Microvilli; Rifampin | 1996 |
[Initial manifestation of tuberculoid leprosy in pregnancy. Guidelines for diagnosis and therapy].
Topics: Adult; Biopsy; Cesarean Section; Dapsone; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant, Newborn; Leprostatic Agents; Leprosy, Tuberculoid; Placenta; Polymerase Chain Reaction; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Skin | 1996 |
Drug resistance in Nepali leprosy patients.
Topics: Adolescent; Adult; Aged; Animals; Dapsone; Drug Resistance; Female; Humans; Leprosy; Male; Mice; Middle Aged; Rifampin | 1996 |
Combined dapsone and clofazimine intoxication.
Topics: Adult; Charcoal; Clofazimine; Dapsone; Drug Overdose; Gastric Lavage; Humans; Leprostatic Agents; Male; Methemoglobinemia; Methylene Blue; Rifampin; Suicide, Attempted; Sulfates | 1996 |
Calcification of peripheral nerves in leprosy.
Topics: Abscess; Adolescent; Adult; Aged; Calcinosis; Child; Cholesterol; Cholesterol Esters; Dapsone; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Lipids; Male; Middle Aged; Peripheral Nervous System Diseases; Rifampin; Suppuration; Ulnar Nerve | 1996 |
Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium leprae; Ofloxacin; Rifampin | 1997 |
Antileprosy drugs, pregnancy and fetal outcome.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Leprostatic Agents; Leprosy; Mice; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rats; Retrospective Studies; Rifampin | 1996 |
Primary resistance to single and multiple drugs in leprosy--a mouse footpad study.
Topics: Adult; Animals; Armadillos; Clofazimine; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mice; Microbial Sensitivity Tests; Mycobacterium leprae; Rifampin; Skin | 1996 |
Dapsone-induced motor polyneuropathy in a patient with leprosy.
Topics: Adult; Anti-Inflammatory Agents; Clofazimine; Dapsone; Diagnosis, Differential; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Motor Neuron Disease; Prednisolone; Rifampin | 1997 |
[Suspected leprosy].
Topics: Adult; Aged; Aged, 80 and over; Dapsone; Diagnosis, Differential; Female; Humans; Leprostatic Agents; Leprosy; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Rifampin; Spain; Thalidomide | 1997 |
Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Methemoglobinemia; Rifampin | 1997 |
Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Monitoring; Granuloma; Histiocytes; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Lymphocytes; Male; Minocycline; Ofloxacin; Recurrence; Rifampin | 1998 |
[Patient with Hansen disease and lepromatous reaction with predominant neural involvement].
Topics: Biopsy; Clofazimine; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Neuritis; Peripheral Nerves; Rifampin | 1998 |
[New WHO recommendations for the treatment of leprosy].
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin; Skin | 1997 |
Leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 1997 |
Why multidrug therapy for multibacillary leprosy can be shortened to 12 months.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin; Time Factors; World Health Organization | 1998 |
Pro- and anti-oxidant effects of some antileprotic drugs in vitro and their influence on super oxide dismutase activity.
Topics: Antioxidants; Clofazimine; Dapsone; Dianisidine; Leprostatic Agents; Ofloxacin; Reactive Oxygen Species; Riboflavin; Rifampin; Superoxide Dismutase; Superoxides | 1998 |
Another view of the therapy of leprosy.
Topics: Animals; Anti-Bacterial Agents; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mice; Minocycline; Rifampin | 1998 |
Cluster of leprosy cases in Kona, Hawaii; impact of the Compact of Free Association.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Contact Tracing; Cultural Deprivation; Dapsone; Emigration and Immigration; Female; Hawaii; Humans; Infant; Infant, Newborn; Leprostatic Agents; Leprosy, Lepromatous; Male; Micronesia; Middle Aged; Palau; Rifampin; Travel | 1999 |
Serum markers of treatment success in leprosy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Child; Clofazimine; Dapsone; Drug Therapy, Combination; E-Selectin; Female; Humans; Immunoglobulin G; Intercellular Adhesion Molecule-1; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Serum Albumin; Treatment Outcome | 1999 |
Histoid leprosy; report of three cases.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin | 1999 |
SIMLEP: a simulation model for leprosy transmission and control.
Topics: BCG Vaccine; Computer Simulation; Dapsone; Drug Therapy, Combination; Humans; Incidence; Leprostatic Agents; Leprosy; Models, Biological; Mycobacterium leprae; Prevalence; Rifampin | 1999 |
Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Topics: Adult; Animals; Biological Assay; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Leprostatic Agents; Leprosy; Male; Mice; Middle Aged; Mycobacterium leprae; Nasal Mucosa; Rifampin; Skin | 1999 |
Trials of preventive therapy.
Topics: Acedapsone; Chemoprevention; Clinical Trials as Topic; Dapsone; Humans; India; Leprostatic Agents; Leprosy; Pacific Islands; Rifampin | 1999 |
Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
Topics: Aged; Clofazimine; Dapsone; DNA, Bacterial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Male; Mycobacterium leprae; Polymerase Chain Reaction; Rifampin | 2000 |
Ominous sign of a disfiguring disease. Leprosy (Hansen's disease).
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Leprosy, Tuberculoid; Male; Rifampin; United States; Vietnam | 2000 |
Clofazimine: new products. Major antileprous drug.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin; Treatment Outcome; World Health Organization | 1999 |
Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
Topics: Adenosine Triphosphate; Biopsy; Clofazimine; Dapsone; DNA, Bacterial; Drug Evaluation; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Treatment Outcome | 1999 |
In vivo modulation of CYP enzymes by quinidine and rifampin.
Topics: Acetylation; Administration, Oral; Adrenergic alpha-Antagonists; Adult; Anti-Arrhythmia Agents; Antibiotics, Antitubercular; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Caffeine; Central Nervous System Stimulants; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dapsone; Debrisoquin; Drug Administration Schedule; Enzyme Inhibitors; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Quinidine; Reference Values; Rifampin; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Theophylline | 2000 |
High prevalence of vitiligo in lepromatous leprosy.
Topics: Adult; Aged; Aged, 80 and over; Clofazimine; Dapsone; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Martinique; Middle Aged; Prevalence; Retrospective Studies; Rifampin; Thalidomide; Vitiligo | 2000 |
Care after cure in leprosy.
Topics: Aftercare; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 2001 |
Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Topics: Acedapsone; Adolescent; Adult; Animals; Child; Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy, Lepromatous; Male; Mice; Mice, Inbred CBA; Mycobacterium leprae; Recurrence; Rifampin | 2000 |
Hansen's disease in a patient with a history of sarcoidosis.
Topics: Anti-Inflammatory Agents; Biopsy; Clofazimine; Dapsone; Dermatologic Agents; Electromyography; Female; Humans; Hydroxychloroquine; Leprostatic Agents; Leprosy, Tuberculoid; Lymphadenitis; Middle Aged; Mycobacterium leprae; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Prednisone; Reticulin; Rifampin; Sarcoidosis; Skin; Triamcinolone | 2000 |
Dapsone drug resistance in the MDT era.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Nepal; Prevalence; Rifampin | 2000 |
Hansen's disease in a native-born, United States resident, after a brief stay in an endemic area abroad.
Topics: Aged; Cell Count; China; Clofazimine; Dapsone; Diabetes Mellitus, Type 1; Emigration and Immigration; Female; Hawaii; Humans; Leprosy; Mycobacterium leprae; Rifampin; United States | 2001 |
Lepromatous leprosy with drug reaction.
Topics: Clofazimine; Dapsone; Drug Eruptions; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Rifampin | 2000 |
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Colony Count, Microbial; Dapsone; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mycobacterium leprae; Ofloxacin; Rifampin | 2000 |
Assessment of antioxidant activity of some antileprotic drugs.
Topics: Adult; Antioxidants; Ascorbic Acid; Bepridil; Biphenyl Compounds; Clofazimine; Dapsone; Humans; Leprostatic Agents; Male; Oxidation-Reduction; Picrates; Rifampin; Spectrophotometry, Ultraviolet | 2001 |
[Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
Topics: Adult; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Erythema Nodosum; Follow-Up Studies; Humans; Immunosuppressive Agents; Leprostatic Agents; Leprosy, Lepromatous; Male; Prothionamide; Rifampin; Thalidomide; Time Factors | 2001 |
Nodular rash in an Indonesian girl.
Topics: Adolescent; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Indonesia; Leprostatic Agents; Leprosy, Lepromatous; Rifampin; Skin; United States | 2001 |
[What is your diagnosis? Sensory motor polyneuropathy in borderline leprosy. Trophic skin disorders with ulcerations, local superinfection on the right foot with right inguinal lymphadenopathy].
Topics: Adolescent; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Rifampin; Time Factors | 2002 |
Effect of peroxidase in complex with basic antileprosy drugs on liver, blood, and functional activity of phagocytes in mice with experimental leprosy.
Topics: Animals; Anti-Inflammatory Agents; Dapsone; Drug Combinations; Horseradish Peroxidase; Leprostatic Agents; Leprosy; Liver; Mice; Mice, Inbred CBA; Neutrophils; Peroxidase; Phagocytes; Rifampin; Time Factors | 2001 |
Treatment of Hansen's disease.
Topics: Clofazimine; Dapsone; Dermatomycoses; Diagnosis, Differential; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin; World Health Organization | 2002 |
Hansen's disease mimicking palmoplantar keratoderma.
Topics: Child; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Keratoderma, Palmoplantar; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin | 2002 |
Short report: Treatment failure in Hansen's disease.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Medical Records; Middle Aged; Recurrence; Retrospective Studies; Rifampin; Texas; Treatment Failure; Treatment Refusal | 2003 |
Determination of antioxidant activity of some drugs using high-pressure liquid chromatography.
Topics: Antioxidants; Ascorbic Acid; Aspirin; Biphenyl Compounds; Chromatography, High Pressure Liquid; Dapsone; Free Radicals; Methyldopa; Picrates; Quercetin; Rifampin; Spectrophotometry, Ultraviolet; Sulfonamides | 2003 |
Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Topics: Acedapsone; Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Rifampin; Skin; Treatment Outcome; World Health Organization | 2003 |
Secondary rifampin resistance following multi-drug therapy--a case report.
Topics: Dapsone; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin | 2003 |
[Two cases of Hansen's disease].
Topics: Aged; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Recurrence; Rifampin; Treatment Outcome | 2003 |
Apparent exacerbation of Hansen's disease despite appropriate antimicrobial therapy.
Topics: Adult; Dapsone; Humans; Leprosy, Tuberculoid; Male; Rifampin; Treatment Outcome | 2003 |
Shiny red-brown papules in a 21-year-old man. Histoid leprosy.
Topics: Adult; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Face; Humans; Leprostatic Agents; Leprosy; Male; Rifampin; Skin Diseases; Thalidomide | 2004 |
Active surveillance of leprosy contacts in country with low prevalence rate.
Topics: Adult; Antibodies, Bacterial; Antigens, Bacterial; Child; Dapsone; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Family Characteristics; Glycolipids; Humans; Leprostatic Agents; Leprosy; Leprosy, Lepromatous; Mycobacterium leprae; Occupational Exposure; Pakistan; Population Surveillance; Prevalence; Rifampin | 2004 |
Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five?
Topics: Dapsone; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin; World Health Organization | 2004 |
[Multi-drug resistant Mycobacterium leprae from patients with leprosy].
Topics: Animals; Base Sequence; Dapsone; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple; Humans; Leprostatic Agents; Leprosy; Mutation; Mycobacterium leprae; Ofloxacin; Rifampin | 2004 |
DNA damage studies in untreated and treated leprosy patients.
Topics: Adolescent; Adult; Aged; Clofazimine; Dapsone; DNA Damage; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin | 2004 |
A case of isolated tuberculoid leprosy of antebrachial medial cutaneous nerve.
Topics: Adult; Antibiotics, Antitubercular; Brazil; Dapsone; Forearm; Granuloma; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Male; Peripheral Nervous System Diseases; Rifampin; Treatment Outcome | 2004 |
Widespread rash in a man with leukemia.
Topics: Aged; Dapsone; Diagnosis, Differential; Endemic Diseases; Exanthema; Humans; Leprosy, Tuberculoid; Leukemia, Lymphoid; Male; Rifampin; Texas | 2005 |
Lepromatous iridocyclitis.
Topics: Adult; Aqueous Humor; Dapsone; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Iridocyclitis; Leprostatic Agents; Leprosy, Lepromatous; Mycobacterium leprae; Prednisone; Rifampin; Skin; Vitreous Body | 2005 |
Chemotherapy of leprosy.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Hypersensitivity; India; Leprosy; Minocycline; Nausea; Ofloxacin; Rifampin; Secondary Prevention; Tuberculosis; World Health Organization | 2004 |
Dapsone syndrome with acute renal failure during leprosy treatment: case report.
Topics: Acute Kidney Injury; Adult; Clofazimine; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Rifampin; Syndrome | 2005 |
Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Topics: Administration, Oral; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Forearm; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Prednisone; Recurrence; Rifampin; Skin; Treatment Outcome | 2005 |
Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
Topics: Adult; Anemia, Aplastic; Brazil; Clofazimine; Dapsone; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin; Risk Assessment; Severity of Illness Index | 2005 |
Remitting seronegative symmetrical synovitis with pitting edema in leprosy.
Topics: Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Edema; Foot; Humans; Leprostatic Agents; Leprosy; Magnetic Resonance Imaging; Male; Methylprednisolone; Rifampin; Synovitis; Treatment Outcome | 2006 |
Renal hypersensitivity vasculitis associated with dapsone.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clofazimine; Cyclophosphamide; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Leprostatic Agents; Leprosy; Methylprednisolone; Rifampin; Tuberculosis, Pulmonary; Vasculitis, Leukocytoclastic, Cutaneous | 2005 |
Chronic inflammatory joint disease revealing borderline leprosy.
Topics: Adult; Arthritis; Chronic Disease; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Electrophysiology; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Musculoskeletal System; Neurons; Radiography; Rifampin; Toes | 2006 |
[Dermopathy and peripheral neuropathy].
Topics: Aged; Clofazimine; Dapsone; Exanthema; Humans; Hypesthesia; Leprostatic Agents; Leprosy; Male; Rifampin; Spain; Venezuela | 2005 |
Epidemiology of leprosy and response to treatment in Hong Kong.
Topics: Clofazimine; Dapsone; Drug Resistance, Bacterial; Drug Therapy, Combination; Hong Kong; Humans; Incidence; Leprostatic Agents; Leprosy; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Rifampin; Steroids; World Health Organization | 2006 |
Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
Topics: Adolescent; Child; Child Welfare; Dapsone; DNA Probes; DNA, Bacterial; Female; Humans; Leprostatic Agents; Leprosy; Male; Mycobacterium leprae; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Predictive Value of Tests; Rifampin; RNA, Ribosomal, 16S | 2006 |
[Guideline for the treatment of Hansen's disease in Japan (Second edition)].
Topics: Clofazimine; Congenital Abnormalities; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Japan; Leprostatic Agents; Leprosy; Rifampin; Surgical Procedures, Operative | 2006 |
Corneal leproma as an initial feature of lepromatous leprosy.
Topics: Aged; Corneal Diseases; Dapsone; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Rifampin | 2006 |
Multidrug therapy regimen for leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Practice Guidelines as Topic; Rifampin; World Health Organization | 2006 |
An unusual rash in an elderly man.
Topics: Age Factors; Aged, 80 and over; Clofazimine; Dapsone; Diagnosis, Differential; Exanthema; Humans; Leprostatic Agents; Leprosy; Male; Rifampin | 2007 |
Multidrug therapy in leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin; World Health Organization | 2006 |
Leprosy in a preschool child--a case report.
Topics: Child, Preschool; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Rifampin; Treatment Outcome | 2007 |
[Polyarthritis and papular eruption revealing leprosy].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Arthritis; Biopsy; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Rifampin; Skin; Treatment Outcome | 2008 |
Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
Topics: Adult; Brazil; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome | 2007 |
Comment on: Arthritis as presenting manifestation of pure neuritic leprosy--a rheumatologist's dilemma.
Topics: Arthritis, Infectious; Biomarkers; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Male; Middle Aged; Prednisolone; Rheumatology; Rifampin; Treatment Outcome | 2008 |
Pure neural leprosy: steroids prevent neuropathy progression.
Topics: Adult; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Electrophysiology; Female; Follow-Up Studies; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Longitudinal Studies; Male; Middle Aged; Peripheral Nervous System Diseases; Prednisone; Prospective Studies; Rifampin; Treatment Outcome | 2007 |
Leprosy as immune reconstitution inflammatory syndrome in HIV-positive persons.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dapsone; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin | 2007 |
[Worsening of leprosy lesions in a Philippine-born patient].
Topics: Adult; Antigens, Bacterial; Dapsone; Facial Dermatoses; Fever; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Mycobacterium leprae; Peripheral Nervous System Diseases; Philippines; Prednisone; Rifampin; Uveitis | 2008 |
[Study of rifampin and dapsone resistance in three patients with recurring leprosy].
Topics: Aged; Dapsone; DNA, Bacterial; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Recurrence; Retrospective Studies; Rifampin | 2008 |
Three indigenous cases of leprosy in the Mississippi delta.
Topics: Aged; Aged, 80 and over; Animals; Armadillos; Biopsy; Clofazimine; Dapsone; Diagnosis, Differential; Disease Reservoirs; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Leprostatic Agents; Leprosy; Male; Mississippi; Mycobacterium leprae; Polymerase Chain Reaction; Rifampin; Skin; Zoonoses | 2008 |
Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
Topics: Aged; Anti-Bacterial Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Middle Aged; Portugal; Prevalence; Retrospective Studies; Rifampin | 2009 |
Tuberculoid leprosy and Type 1 lepra reaction.
Topics: Adult; Biopsy; Clofazimine; Dapsone; Diagnosis, Differential; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Male; Neural Conduction; Philippines; Rifampin; Sicily; Travel | 2008 |
[Sensory-motor neuropathy: a slow and misleading case of leprosy].
Topics: Adrenal Cortex Hormones; Aged; Aspirin; Clofazimine; Dapsone; Diagnosis, Differential; Female; Humans; Leprostatic Agents; Leprosy; Macrophages, Peritoneal; Mycobacterium lepraemurium; Rifampin | 2008 |
Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Middle Aged; Ofloxacin; Prednisone; Rifampin | 2008 |
[Lepromatous leprosy revealed by a swollen hands syndrome].
Topics: Adult; Anti-Bacterial Agents; Dapsone; Edema; Hand Injuries; Humans; Leprosy, Lepromatous; Male; Mycobacterium leprae; Rifampin; Syndrome; Synovitis | 2009 |
Autochthonous leprosy in metropolitan France presenting with a diffuse infiltration of the face and febrile illness.
Topics: Biopsy, Needle; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Facial Dermatoses; Female; Fever; Follow-Up Studies; France; Humans; Immunohistochemistry; Leg Dermatoses; Leprosy, Lepromatous; Middle Aged; Rifampin; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2009 |
Question: Can you identify this condition? Tuberculoid leprosy.
Topics: Adult; Asian People; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Mycobacterium leprae; Rifampin; Skin Diseases, Bacterial; Skin Tests | 2009 |
Leprosy: not always an easy diagnosis and often a management challenge.
Topics: Adult; Aged, 80 and over; Arm; Back; Clofazimine; Dapsone; Diagnosis, Differential; Drug Hypersensitivity; Drug Therapy, Combination; Face; Female; Forearm; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Mycobacterium leprae; Rifampin; Treatment Outcome | 2009 |
Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprostatic Agents; Leprosy; Male; Malta; Program Evaluation; Prothionamide; Rifampin; Treatment Outcome | 2008 |
A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Topics: Adolescent; Adult; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Nepal; Retrospective Studies; Rifampin; Treatment Outcome | 2008 |
[Trends in therapy for Hansen disease].
Topics: Dapsone; Humans; Japan; Leprosy; Minocycline; Plant Oils; Quinolones; Rifampin | 2009 |
Tattoos and paucibacillary leprosy.
Topics: Dapsone; Female; Humans; Leprostatic Agents; Leprosy; Middle Aged; Rifampin; Tattooing | 2009 |
A case of Actinomycotic mycetoma involving the right foot.
Topics: Actinomycetales; Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Foot Dermatoses; Gentian Violet; Humans; India; Male; Middle Aged; Mycetoma; Phenazines; Rifampin; Suppuration; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |
Nonpruritic erythematous plaques.
Topics: Adult; Animals; Armadillos; Biopsy; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Erythema; Hand Dermatoses; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Rifampin; Skin; Zoonoses | 2009 |
Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
Topics: Adult; Agranulocytosis; Anemia, Hemolytic; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Rifampin | 2009 |
Facial tuberculoid leprosy: case report.
Topics: Adult; Cellulitis; Dapsone; Diagnosis, Differential; Facial Dermatoses; Female; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Mycobacterium leprae; Prednisolone; Rifampin | 2011 |
[Lepra reaction and pregnancy].
Topics: Brazil; Dapsone; Delayed Diagnosis; Facial Dermatoses; Female; Foot Dermatoses; Hand Dermatoses; Humans; Hypesthesia; Immunity, Cellular; Leprosy, Tuberculoid; Occupational Exposure; Prednisone; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Spain | 2010 |
Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience.
Topics: Acute Disease; Aged; Arthritis; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Exanthema; Glucocorticoids; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Peripheral Nerves; Peripheral Nervous System Diseases; Rifampin; Treatment Outcome | 2009 |
Clinical-pathological conference: case 3.
Topics: Adult; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Infections; Leishmaniasis; Leprostatic Agents; Leprosy, Multibacillary; Male; Minocycline; Mycobacterium leprae; Ofloxacin; Palate; Prednisone; Rifampin; Strongyloidiasis; Treatment Outcome | 2010 |
Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Hyperpigmentation; Leprostatic Agents; Leprosy; Minocycline; New York; Patient Preference; Rifampin | 2010 |
Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
Topics: Bacterial Proteins; Dapsone; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Ear, External; Humans; Leprostatic Agents; Leprosy; Mexico; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Prevalence; Rifampin; Sequence Analysis, DNA | 2010 |
[Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].
Topics: Adrenal Cortex Hormones; Adult; Anti-HIV Agents; Dapsone; Diagnostic Errors; Female; HIV Infections; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Neuritis; Nevirapine; Rifampin; Senegal; Stavudine; Tinea Capitis | 2011 |
Concurrent Hansen disease and pulmonary tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Comorbidity; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Male; Rifampin; Tuberculosis, Pulmonary | 2011 |
Childhood leprosy: lest we forget.
Topics: Adolescent; Chemoprevention; Child; Child Welfare; Dapsone; Female; Humans; India; Leprostatic Agents; Leprosy; Male; Prevalence; Retrospective Studies; Rifampin | 2011 |
Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur).
Topics: Adolescent; Adult; Body Mass Index; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy; Male; Prospective Studies; Rifampin; Risk Factors | 2011 |
Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Topics: Animals; Bacterial Proteins; Biopsy; Clofazimine; Cross-Sectional Studies; Dapsone; Dihydropteroate Synthase; DNA Gyrase; Drug Resistance, Bacterial; Genetic Predisposition to Disease; Humans; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Rifampin | 2011 |
Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Middle Aged; Philippines; Prospective Studies; Recurrence; Rifampin; Risk Factors; Time Factors; World Health Organization | 2011 |
Transmission of dapsone-resistant leprosy detected by molecular epidemiological approaches.
Topics: Bacterial Proteins; Dapsone; Humans; India; Leprostatic Agents; Leprosy; Molecular Epidemiology; Mutation; Mycobacterium leprae; Philippines; Rifampin | 2011 |
Evaluation of multi-drug therapy for leprosy in the United States using daily rifampin.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Biopsy; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Health Surveys; Humans; Leprostatic Agents; Leprosy; Male; Medical Records; Middle Aged; Retrospective Studies; Rifampin; Secondary Prevention; Treatment Outcome; United States | 2011 |
Facial reversal reaction: a dermatological emergency.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; B-Lymphocytes; CD3 Complex; Clofazimine; Dapsone; Drug Therapy, Combination; Emergencies; Face; Facial Dermatoses; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Male; Prednisone; Receptors, Cell Surface; Rifampin; T-Lymphocytes; Treatment Outcome | 2012 |
A case of leprosy mistaken for cutaneous sarcoidosis.
Topics: Adult; Clofazimine; Dapsone; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Rifampin; Sarcoidosis; Skin Diseases, Bacterial | 2012 |
Atypical Hansen's disease presenting as florid verrucous plaques on the lower extremities: a case report.
Topics: Biopsy; Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Glucocorticoids; Humans; Leg Dermatoses; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Philippines; Prednisone; Rifampin | 2012 |
Florid reactive periostitis ossificans of long bones and digits associated with reaction in a patient with leprosy.
Topics: Adolescent; Clofazimine; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Osteitis; Periostitis; Radiography; Rifampin; Treatment Outcome | 2012 |
Present situation of leprosy in Japan, 2006-2010: analysis of drug resistance in new registered and relapsed cases by molecular biological methods.
Topics: Adult; Aged; Dapsone; Drug Resistance, Bacterial; Female; Humans; Japan; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Polymerase Chain Reaction; Recurrence; Registries; Rifampin | 2012 |
Dapsone induced eosinophilic pneumonia.
Topics: Aged; Biopsy; Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Pulmonary Eosinophilia; Rifampin | 2012 |
Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages.
Topics: Animals; Blotting, Western; Clofazimine; Dapsone; Gene Expression Profiling; Humans; Interferons; Leprostatic Agents; Lipid Metabolism; Macrophages; Mycobacterium leprae; Rats; Rats, Nude; Real-Time Polymerase Chain Reaction; Rifampin | 2012 |
Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Patient Compliance; Rifampin; World Health Organization | 2012 |
Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic; Brazil; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Hematocrit; Hematologic Tests; Hemoglobins; Hemolysis; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome; World Health Organization; Young Adult | 2012 |
A young man with livid facial nodules and a loss of eyebrows.
Topics: Adult; Alopecia; Clofazimine; Dapsone; Eyebrows; Facial Dermatoses; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Rifampin | 2013 |
[Histoid leprosy].
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Granuloma; Guinea; Histiocytes; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Morocco; Rifampin; Staining and Labeling | 2013 |
An under-recognized cause of polyarthritis: leprosy.
Topics: Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Clofazimine; Dapsone; Delayed Diagnosis; Diagnosis, Differential; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Prednisolone; Rifampin; Treatment Outcome | 2013 |
A case of Hansen Disease presenting as tinea versicolor.
Topics: Clofazimine; Contraindications; Dapsone; Delayed Diagnosis; Diagnostic Errors; Humans; Hypesthesia; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Minocycline; Mycobacterium leprae; Rifampin; Tinea Versicolor; Young Adult | 2013 |
Drug resistance in patients with leprosy in the United States.
Topics: Anti-Bacterial Agents; Dapsone; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Leprosy; Mycobacterium leprae; Polymerase Chain Reaction; Rifampin; Sequence Analysis, DNA; United States | 2014 |
Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.
Topics: Adult; Analysis of Variance; Catalase; Clofazimine; Cytochrome P-450 CYP2C19; Dapsone; Drug Therapy, Combination; Female; Glutathione; Heinz Bodies; Humans; Leprostatic Agents; Leprosy; Male; Methemoglobin; Middle Aged; Oxidation-Reduction; Oxidative Stress; Protein Binding; Reactive Oxygen Species; Rifampin; Time Factors; Treatment Outcome; Young Adult | 2014 |
[Borderline lepromatous leprosy].
Topics: Adult; Biopsy; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Multibacillary; Morocco; Neglected Diseases; Rifampin; Skin | 2014 |
Optic nerve involvement in a borderline lepromatous leprosy patient on multidrug therapy.
Topics: Anti-Inflammatory Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; India; Leprostatic Agents; Leprosy, Borderline; Male; Middle Aged; Ophthalmoscopy; Optic Disk; Optic Nerve; Prednisolone; Rifampin; Visual Acuity; Visual Field Tests | 2013 |
Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
Topics: Adolescent; Adult; Bacterial Proteins; Biopsy; Child; Colombia; Dapsone; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Genotype; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Middle Aged; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Retrospective Studies; Rifampin; Young Adult | 2014 |
[Rapid detection of mutations related to Mycobacterium leprae drug resistance by using Hp-rPCR (hairpin primer- real time PCR) method].
Topics: Anti-Bacterial Agents; Base Sequence; Codon; Dapsone; DNA Primers; DNA, Bacterial; Double-Blind Method; Drug Resistance, Bacterial; Genes, Bacterial; Leprostatic Agents; Molecular Sequence Data; Mutation; Mycobacterium leprae; Quinolones; Real-Time Polymerase Chain Reaction; Rifampin | 2014 |
Leprosy.
Topics: Aged, 80 and over; Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy; Male; Mycobacterium leprae; Rifampin; Skin; Treatment Outcome | 2014 |
Six years' follow-up of multibacillary leprosy patients treated with uniform multi-drug therapy in China.
Topics: Adolescent; Adult; Aged; Child; China; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Middle Aged; Rifampin; Skin; Treatment Outcome; Young Adult | 2015 |
Pediatric cutaneous leishmaniasis in an endemic region in India.
Topics: Administration, Oral; Antimony Sodium Gluconate; Child, Preschool; Dapsone; Female; Humans; Incidence; India; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Polymerase Chain Reaction; Pulsed Radiofrequency Treatment; Retrospective Studies; Rifampin | 2014 |
Evaluation on activity of cytochrome p450 enzymes in turbot via a probe drug cocktail.
Topics: Animals; Antitubercular Agents; Area Under Curve; Caffeine; Chlorzoxazone; Cytochrome P-450 Enzyme System; Dapsone; Enzyme Induction; Flatfishes; Folic Acid Antagonists; Muscle Relaxants, Central; Nucleic Acid Synthesis Inhibitors; Phosphodiesterase Inhibitors; Rifampin | 2014 |
A man with facial changes.
Topics: Clofazimine; Dapsone; Facies; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium leprae; Nasal Septal Perforation; Nasal Septum; Peripheral Nervous System Diseases; Rifampin; Treatment Outcome; Young Adult | 2014 |
Drug resistance in Mycobacterium leprae from patients with leprosy in China.
Topics: Adult; Bacterial Proteins; China; Dapsone; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Leprostatic Agents; Leprosy; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Prevalence; Rifampin | 2015 |
Borderline tuberculoid leprosy in childhood onset systemic lupus erythematosus patient.
Topics: Adolescent; Autoantibodies; Child; Dapsone; Humans; Leprostatic Agents; Leprosy, Paucibacillary; Lupus Erythematosus, Systemic; Male; Mycobacterium leprae; Rare Diseases; Rifampin | 2015 |
An inflammatory myopathy unmasks a case of leprosy in an Italian patient.
Topics: Dapsone; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Myositis; Rifampin; Treatment Outcome | 2015 |
Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
Topics: Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Middle Aged; Mycobacterium leprae; Rifampin | 2015 |
Diffuse Lepromatous Leprosy Due to Mycobacterium lepromatosis in Quintana Roo, Mexico.
Topics: Adult; Base Sequence; Clofazimine; Dapsone; DNA, Bacterial; Drug Combinations; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Mexico; Mycobacterium; Rifampin; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2015 |
Leproma Presenting as a Nasal Cavity Mass.
Topics: Biopsy; Clofazimine; Dapsone; Diagnosis, Differential; Endoscopy; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Lepromatous; Middle Aged; Nasal Cavity; Nasal Obstruction; Olfaction Disorders; Rifampin; Tissue Adhesions | 2015 |
Autochthonous borderline tuberculoid leprosy in a man from Florida.
Topics: Aged; Dapsone; Florida; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Male; Rifampin | 2016 |
Wade histoid leprosy revisited.
Topics: Adolescent; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin | 2016 |
Editorial Commentary: Drug-Resistance in Leprosy: Moving Toward Understanding the Scope of the Problem and How to Tackle It.
Topics: Dapsone; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium leprae; Rifampin | 2016 |
Transmission of Drug-Resistant Leprosy in Guinea-Conakry Detected Using Molecular Epidemiological Approaches.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; Dapsone; DNA, Bacterial; Drug Resistance, Microbial; Female; Genome, Bacterial; Guinea; Humans; Leprosy; Male; Mycobacterium leprae; Rifampin; Sequence Analysis, DNA; Skin | 2016 |
Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; Child; Colombia; Dapsone; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Leprostatic Agents; Leprosy; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Recurrence; Rifampin; Sentinel Surveillance; Skin; Young Adult | 2016 |
Leprosy in the UK.
Topics: Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy; Peripheral Nervous System Diseases; Rifampin; United Kingdom | 2016 |
Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
Topics: Antigens, Bacterial; Dapsone; Drug Therapy, Combination; Graft Rejection; Humans; Immune Reconstitution Inflammatory Syndrome; Immunosuppression Therapy; Kidney Transplantation; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Prednisone; Rifampin; Skin; T-Lymphocytes, Regulatory; Treatment Outcome | 2017 |
qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
Topics: Bacterial Proteins; Dapsone; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Leprostatic Agents; Leprosy; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Skin | 2017 |
Painless Nodular Rash in a Young Man.
Topics: Adult; Clofazimine; Dapsone; Diagnosis, Differential; Exanthema; Humans; Leprostatic Agents; Leprosy; Male; Mycobacterium leprae; Patient Care Management; Rifampin; Skin | 2017 |
A case of leprosy in central Florida.
Topics: Aged; Biopsy; Dapsone; Diagnosis, Differential; Florida; Humans; Leprostatic Agents; Leprosy; Male; Mandatory Reporting; Mycobacterium leprae; Rifampin; Skin; Treatment Outcome | 2017 |
Leprosy in Nonimmigrant Canadian Man without Travel outside North America, 2014.
Topics: Aged; Anti-Bacterial Agents; Canada; Dapsone; Drug Therapy, Combination; Florida; Humans; Leprostatic Agents; Leprosy; Male; Mycobacterium leprae; Ofloxacin; Rifampin; Travel | 2018 |
Multiple cranial nerve palsies secondary to a recurrence of Hansen's disease.
Topics: Adult; Cranial Nerve Diseases; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Positron Emission Tomography Computed Tomography; Prednisolone; Recurrence; Rifampin | 2018 |
Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biopsy, Needle; Brazil; Colombia; Dapsone; DNA Gyrase; Drug Resistance, Bacterial; Endemic Diseases; Epidemiological Monitoring; Global Health; Humans; India; Leprosy; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Prospective Studies; Recurrence; Rifampin; Sentinel Surveillance; Skin; Surveys and Questionnaires; World Health Organization | 2018 |
Chronic, persistent angioedema and sinusitis-like presentation of multibacillary leprosy.
Topics: Adolescent; Angioedema; Biopsy; Chronic Disease; Clofazimine; Dapsone; Developing Countries; Diagnosis, Differential; Drug Therapy, Combination; Facial Dermatoses; Follow-Up Studies; Humans; India; Leprosy, Multibacillary; Male; Rifampin; Sinusitis; Skin | 2018 |
Biomimetic Solid Lipid Nanoparticles of Sophorolipids Designed for Antileprosy Drugs.
Topics: Biomimetic Materials; Calorimetry, Differential Scanning; Dapsone; Drug Carriers; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Kinetics; Lipids; Nanoparticles; Rifampin; Temperature | 2018 |
Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
Topics: American Samoa; Biopsy; Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Leprostatic Agents; Leprosy; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Rifampin; Skin | 2018 |
Multiple livid-erythematous macules and plaques with slight scaling in a young man.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Erythema; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin; Treatment Outcome; Young Adult | 2018 |
Widespread Dermatophytosis in a Patient Treated for Leprosy Type II Reactional State after MDT/WHO-MB Release.
Topics: Antifungal Agents; Brazil; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Prednisone; Recurrence; Rifampin; Terbinafine; Thalidomide; Tinea; Trichophyton; Young Adult | 2018 |
Hyperpigmented Macule on the Palm and Diminished Sensation.
Topics: Adult; Dapsone; Drug Therapy, Combination; Female; Hand; Hand Dermatoses; Humans; Hyperpigmentation; Hypesthesia; Leprostatic Agents; Leprosy, Tuberculoid; Rifampin | 2018 |
Atypical rash.
Topics: Adult; Dapsone; Exanthema; Female; Humans; Leprostatic Agents; Leprosy; Rifampin | 2019 |
Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.
Topics: Adult; Alleles; China; Clofazimine; Cohort Studies; Dapsone; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Female; HLA-B13 Antigen; Humans; Incidence; Leprostatic Agents; Leprosy; Male; Middle Aged; Prospective Studies; Rifampin | 2019 |
4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.
Topics: Alzheimer Disease; Clofazimine; Cognitive Dysfunction; Coronavirus Infections; COVID-19; Dapsone; Humans; Inflammasomes; Interleukin-1beta; Leprosy; NLR Family, Pyrin Domain-Containing 3 Protein; Pandemics; Parkinsonian Disorders; Pneumonia, Viral; Rifampin; Spike Glycoprotein, Coronavirus; Toll-Like Receptor 2 | 2020 |
The Clinical Trend of Leprosy from 2000 to 2016 in Kaohsiung, a Major International Harbor City in Taiwan, Where Leprosy is Almost Eradicated.
Topics: Adult; Aged; Dapsone; Disease Eradication; Female; Humans; Leprosy; Leprosy, Lepromatous; Male; Middle Aged; Mycobacterium leprae; Retrospective Studies; Rifampin; Skin; Taiwan | 2021 |
Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
Topics: Clofazimine; Dapsone; Disease Progression; Drug Therapy, Combination; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Rifampin; Treatment Outcome | 2020 |
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.
Topics: Adolescent; Adult; Alleles; Biomarkers; Case-Control Studies; Clofazimine; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Female; HLA-B13 Antigen; Humans; Indonesia; Leprostatic Agents; Leprosy; Logistic Models; Male; Rifampin; Risk Assessment; Syndrome; Young Adult | 2020 |
Low rate of relapse after twelve-dose multidrug therapy for hansen's disease: A 20-year cohort study in a brazilian reference center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brazil; Child; Child, Preschool; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Incidence; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Mycobacterium leprae; Recurrence; Retrospective Studies; Rifampin; Skin; Young Adult | 2021 |
Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.
Topics: Antigens, Bacterial; Bacterial Proteins; Clofazimine; Dapsone; Heat-Shock Proteins; Host-Pathogen Interactions; Humans; Hydrophobic and Hydrophilic Interactions; Leprostatic Agents; Leprosy; Molecular Chaperones; Mycobacterium leprae; Protein Binding; Protein Structure, Secondary; Rifampin | 2022 |
Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis.
Topics: Abattoirs; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Dapsone; Diagnosis, Differential; Humans; Isoniazid; Latent Tuberculosis; Leprostatic Agents; Leprosy, Borderline; Leprosy, Multibacillary; Male; Middle Aged; Prednisolone; Rifampin; Thrombophlebitis | 2021 |
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
Topics: Anti-Bacterial Agents; Brazil; Cross-Sectional Studies; Dapsone; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Microbial Sensitivity Tests; Mycobacterium leprae; Recurrence; Rifampin | 2022 |
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study.
Topics: Acitretin; Anti-Bacterial Agents; Biological Factors; Biological Products; Clindamycin; Dapsone; Dicloxacillin; Drug Utilization; Hidradenitis Suppurativa; Humans; Isotretinoin; Rifampin; Tetracyclines | 2022 |
Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.
Topics: Animals; Dapsone; Drug Resistance, Bacterial; Leprostatic Agents; Leprosy; Mice; Mycobacterium leprae; Ofloxacin; Rifampin | 2022 |
Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
Topics: Comoros; Dapsone; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin | 2022 |
A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions.
Topics: Case-Control Studies; Dapsone; Drug Therapy, Combination; Humans; Hypersensitivity; Leprostatic Agents; Leprosy; Ofloxacin; Rifampin | 2023 |
High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.
Topics: Cross-Sectional Studies; Dapsone; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; India; Leprostatic Agents; Leprosy; Mycobacterium leprae; Ofloxacin; Rifampin | 2023 |